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Angiotensin II induced glomerular injury: Is there a role for free 3 mmHg; P , 0.01). Mean BP decrease was 10 6 2 mmHg in group
III (P , 0.05 vs controls), and 12 6 1 mmHg in group IV (P , 0.01radicals? J.M. Galceran, E.A. Jaimes, and L. Raij, VAMC & Univ.
vs controls). These findings implicate kinins as necessary mediators forMinnesota, Minneapolis, MN, USA. Angiotensin II (Ang II) may partic-
the full hypotensive effect of aFGF in vivo. The underlying mechanismipate in the progression of renal injury by hemodynamic but also non-
involved is yet to be clarified, but the reduced response in BNK orhemodynamic effects. Ang II increases production of superoxide
ellagic treated-kininogen depleted rats suggests that aFGF could induce(O2.2 ) in vascular smooth muscle cells. Moreover, free radicals have
synthesis of kinins.been shown to be second messengers to certain growth factors. We
have investigated whether Ang II increases O2.2 production in mesangial
cells (MC) and if this enhanced production is related to MC hypertro-
Serum and urinary beta 2-microglobulin and IST correlation with dif-phy. Treatment of MC with Ang II (1028 – 1025M) caused a dose
ferent target organ damage in mild essential hypertension (MEH).dependent increase in O2.2 production (cpm/mg protein; mean 6 SE;
N.S. Jabary, M. Arranz, R. Bustamante, J. Herruzo, J. Martin, C. Esteb-n 5 528) as measured by lucigenin luminescence: Control 85 6 7;
anzez, and J. Bustamante, Hypertensive Unit, University Hospital, Valla-Ang II (M): 1028 93 6 6; 1027 118 6 8*; 1026 167 6 5*; 1025 214 6 17*.
dolid (Spain). Objective: The aim of the present study was to evaluate*P , 0.05 vs Control by ANOVA. The AT1 blocker losartan (LOS) changes in serum and urinary beta-2 microglobulin (B2M) and itsand the NADH/NADPH inhibitor diphenylene iodinium (DPI)
correlation with different target organ damage in mild essential hyper-blocked Ang II induced O2.2 production: Ang II 1025M 1 LOS 1026M tension (left ventricular hypertrophy (LVH), microalbuminruia (MA)81 6 12* and Ang II 1025M 1 DPI 110 mM 21 6 3*; *P , 0.05 vs Ang
and retinal vascular lesions). Design and Methods: 110 patients agedII 1025M. Ang II (102921025M) dose dependently increased protein
between 20–78, 42 males (53.3 6 9 y) and 57 female (58.2 6 10 y).synthesis (as measured by 3H-leucine incorporation) 1.3 to 3.4 fold
Serum and urinary B2M were determined. All patients are investigatedabove Control (P , 0.05 vs Control at all concentrations of Ang II).
to determine different organs damage (LVH, MA and retinal vascularBoth LOS and DPI independently prevented Ang II induced MC
lesions). Assessment of LVH was made by (echocardiography). 24-hypertrophy, thus establishing the specificity of Ang II action and the
hour urinary albumin excretion was determined and albumin concen-necessary participation of O2.2 in the signalling mechanism. To further tration was measured in a morning spot urine and expressed as a mg/study the role of free radicals in MC hypertrophy we tested the effect gr/cr excretion. Retinal Funduscopic examination was evaluated byof Catalase (CAT) in our model. Addition of CAT 1600 U/ml to media the same ophthalmologist, establishing a new classification. Differentpartially prevented but did not blunt Ang II induced hypertrophy ophthalmic lesions (diffuse narrowing, focal narrowing, crossing A-V(cpm/106 alive cells; mean 6 SE): Control 15027 6 734; Ang II 1025M changes, exudates and hemorrhages were punctuated between 0–2050871 6 1854* and Ang II 1025M 1 CAT 32882 6 1465*1. *P , 0.05 points, with a maximum of 100 points). Results: Serum B2M (1.5 6vs Control, 1P , 0.05 vs Ang II 1025M. These results suggest that 0.8 mg/dl) and urinary B2M (0.23 6 0.6 mg/l) was significantly increasedboth O2.2 and H2O2 synthesis are necessary for Ang II induced MC in hypertensive patients (P , 0.01). There were no significant correla-hypertrophy. Our studies strongly suggest that free radicals generated tion between target organic damage and serum and urine B2M concen-
by MC in response to Ang II may be previously unrecognized mediator tration. Conclusions: Serum and urinary B2M is increased in MED.
in nonhemodynamic actions of Ang II in the pathophysiology of pro- No correlation was found between LVH, MA and fundoscopic lesions
gressive glomerular injury. and serum and urinary B2M.
Antihypertensive effect of acidic fibroblast growth factor (aFGF) is Monoclonal antibody analysis of crescentic membranous glomerulo-
mediated by kinins. I. Saez de Tejada, L. Orte•, F. Carceller, A. Fernan- nephropathy. P. Arrizabalaga, A. Sans, A. Torras, A. Darnell, and
dez, B. Cuevas, G. Gimenez-Gallego*, and P. Cuevas, Dpt. Investiga- L. Revert, Nephrology Service, Hospital Clı´nic1, Hospital General de
cio´n y •S. Nefrologı´a Hospital Ramo´n y Cajal. *CSIC. Madrid. Espan˜a. Manresa, Barcelona, Spain. Idiopathic membranous glomerulonephro-
aFGF causes, when infused intravenously to experimental animals, an pathy (MG) has a rather benign prognosis. Acute renal failure with
acute and transient endothelium-dependent decrease in blood pres- cellular crescents superimposed on MG is unusual and its pathogenesis
sure. However, this response is not found or is very small in vitro. is not fully understood. We report 3 patients with crescentic MG who
One possible explanation for this discrepancy is that plasma mediators, showed strong glomerular and interstitial infiltration of leucocytes
perhaps kinins, are necessary for a full FGF-induced vasodilation. We (CD45), T lymphocytes (CD3), helper/inducer T cells (CD4), cytotoxic/
studied the hypotensive response to 1 mg iv aFGF in rats: Group I: suppressor T cells (CD8), and monocyte-macrophages (CD14). A simi-
control Wistar (n 5 12); Group II: treated with a bradykinin receptor lar number of CD41 and CD81 cells contributed to T cellularity
antagonist (Na-adamantaneacetyl-D-Arg-[Hyp3, Thi5,8, D-Phe7]-bradyki- within the glomerular tuft, whereas CD41 cells were predominant
nin) at doses of 58 mg(n 5 6) or 420 mg(n 5 6); Group III: depleted over CD81 cells in the crescents. Intercellular adhesion molecule-1
of kininogen after repeated injections of cephalin-ellagic acid (4 to 6, (ICAM-1) antigens (CD54) were found on renal vascular endothelium,
400 ml each, 6–8 min apart; n 5 5); Group IV: kininogen-deficient interstitial cellular aggregates and proximal tubular epithelial cells.
BNK (n 5 18). Mean BP was measured directly through a femoral The case reports illustrate the contribution of macrophages and T cells
catheter. As compared with group I rats the hypotensive response to bearing predominantly CD41 phenotype to cellular crescents, and
aFGF was significantly less pronounced in the rest of the groups. The the abnormal expression of ICAM-1 antigens on proximal tubular
hypotensive effect in group II was reduced in comparison with controls epithelial cells. Both features suggest that cell-mediated immunity may
play a role in the transformation of crescentic MG.by 38% with 58 mg and by 60% with the 420 mg dose (9 6 1 vs 22 6
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Leucocyte infiltration and ICAM-1 mediated cell interactions in IgA condition), 30 and 50 mM glucose concentrations was examined over
24 hours and results were compared with those obtained in a previousnephropathy (IgAN). P. Arrizabalaga, M. Sole´, L.L. Quinto´, C. Ascaso,
P. Engel, R. Vilella, A. Torras, and A. Darnell, S. of Nephrology, similar study made in murine cells. Methodology: H2O2 was quantified
by microfluorimetry of the probe dichlorofluorescein diacetate (DCFH-Pathology and Immunology, Epidemiological and Biostatistical Unit,
Hospital Clı´nic, Barcelona, Spain. Mononuclear leucocytes are impli- DA), incubated in cultures at 20 mM for 20 minutes and washed before
the addition of study conditions. With this procedure, the oxidationcated in IgAN. Renal leucocyte recruitment is mediated by adhesive
interactions between leucocytes and their ligands on renal cells. We of the intracellular DCFH to the highly fluorescent compound 29,79-
DCF is determined, being the degree of fluorescence directly propor-have assessed interstitial and glomerular cellular infiltration by avidin-
biotin-peroxidase staining with monoclonal antibodies (MA) against tional to H2O2 generation. Results: There was a H2O2 production in
human cells significantly higher since the second hour when they wereleucocytes (CD45), b2 integrin (CD18), monocyte-macrophages
(CD14), T (CD3) and T-cell subsets (CD4,CD8), intercellular adhesion exposed to 30 and 50 mM glucose (without significative differences
between them) comparing with the constitutive synthesis under glucosemolecule-1 (ICAM-1) (CD54) and HLA-II antigens. We analysed their
relation with ICAM-1 expression on proximal tubule epithelium (PTE) 5.5 mM (P , 0.01). At 24 hours the relative production was 12-fold
the basal value for physiologic glucose and 16-fold for both hypertonicin sequential renal sections of 57 patients with IgAN stratified according
to the interstitial cellular infiltration (ICI), graded from 1 to 41 by concentrations. This response pattern was different to that previously
detected in murine mesangial cells, in which H2O2 generation did notlight microscopy. The number of interstitial leucocytes identified by
any of the above MA was significantly higher depending on the degree show significative differences between 5.5 and 30 mM glucose during
an exposition time of 8 hours; on the contrary, there were significantlyof ICI. In IgAN without (n 5 15) and with ICI 5 1 (n 5 11), ICAM-1
expression on endothelium was unchanged with respect to that ob- higher values for 50 mM glucose: 14-fold the basal value at 8th hour
versus 7-fold in the other 2 concentrations (P , 0.01). Conclusion:served in normal kidney; the PTE was negative for this stain. In IgAN
with ICI 5 21 (n 5 14), 31 (n 5 11) and 41 (n 5 6), moreover, The hypertonic glucose-induced oxidative stress is less intense in hu-
man than in murine mesangial cells. However, in murine cells anICAM-11 stain was seen on PTE; the median value of its quantitative
expression (QE) was 0.1, 0.1 and 0.2 respectively (P 5 0.0004). The important concentration in human clinical consideration as was the 30
mM glucose does not condition a higher H2O2 production than thetubular ICAM-11 stain was significantly associated with the interstitial
leucocytes identified by the MA mentioned above, and correlated (P , physiologic 5.5 mM glucose.
0.02) and CD451 (r 5 0.59), CD141 (r 5 0.54) and CD31 (r 5 0.51)
interstitial leucocytes in IgAN with ICI $ 21. Interstitial ICAM-11
and CD181 cells were correlated (r 5 0.85). Correlation was found Inhibitory effect of losartan and enalaprilat on the hydrogen peroxide
production by human mesangial cells exposed to high glucose. L.M.between ICAM-11 PTE and CD451 (r 5 0.87, P , 0.002), CD141
(r 5 0.58, P , 0.01) and CD81 (r 5 0.68, P , 0.02) glomerular Ruiz-Mun˜oz, A. Solı´s, R. Mun˜iz, J.M. Martı´nez, and I. Lampreabe,
Department of Nephrology, Cruces Hospital, Basque Country Univer-leucocytes. Our results suggest that tubular and interstitial ICAM-11
cells may participate in interstitial cell-mediated adhesive interactions. sity, Vizcaya, Spain. Introduction: An antioxidant action of angiotensin
converting-enzyme inhibitors (ACEI) has been related with their pro-Epithelial tubular cells expressing ICAM-1 may be a marker of tubulo-
interstitial disturbance upregulated by interstitial and glomerular T- tective effect in diabetic nephropathy. Objective: The comparative
effect of losartan, an antagonist of angiotensin type 1 (AT-1) receptors,cells and macrophages in IgAN.
and the ACEI enalaprilat on in vitro hydrogen peroxide (H2O2) produc-
tion by human mesangial cultures exposed to physiologic (5.5 mM)
and hypertonic (30 and 50 mM) glucose concentrations was studiedRenal interstitial morphometric study: influence of hypertension and
correlation with renal function. N.S. Jabary, J. Herruzo, L. Sanchez, J. during 24 hours. Methodology: H2O2 was quantified by microfluorime-
try of the probe dichlorofluorescein diacetate (DCFH-DA), incubatedMartin, C. Estebanez, and J. Bustamante, Hypertensive Unit, University
Hospital, Valladolid (Spain). Objective: Increased renal interstitial fi- in cultures at 20 mM for 20 minutes and washed before the addition of
study conditions. With this procedure, the oxidation of the intracellularbrosis is associated to any forms of glomerulonephritis (GN) and hyper-
tension. Tubulointerstitial damage that mediates impaired renal func- DCFH to the highly fluorescent compound 29,79-DCF is determined,
being the degree of fluorescence directly proportional to H2O2 genera-tion is not new. Many studies have pointed pronositic significance of
severe interstitial disease in GN. Functional parameters are often best tion. Each type of assay was evaluated three times in quadruplicated
wells. Results: H2O2 production by mesangial cells exposed to 30 andcorrelated with quantitative scoring of tubulointerstitial volume. This
is a morphometric study designed to investigate the influence of hyper- 50 mM glucose was significantly higher at 24 hours (P , 0.01), without
significative differences between them, compared to cells exposed totension on the interstitial surface in renal biopsies and its correlation
with renal function. Design and Methods: Interstitial area is measured 5.5 mM glucose. Addition of 1 mM enalaprilat significantly inhibited
(P , 0.01) the values obtained with the hypertonic glucoses and didby Point-Counting Technique in 49 renal biopsied patients. Mean age
42.1 6 10 (14–80 y), 34 males (59.6%) and 23 females (40.4%). Divided not modify those obtained with the physiologic glucose. A significant
decrease (P , 0.01) of H2O2 production for the three glucose concentra-on the basis of renal pathology, into three different groups. Group I:
11 patients with normal renal biopsy (considered as control). Group tions was also obtained in assays with 1 mM and 10 mM losartan; this
effect was more intense than with enalaprilat (P , 0.01). Conclusion:II: 21 patients with focal and membranous GN. Group III: 17 patients
with ischemic renal changes, hypertension, was the main clinical diag- Both ACEI and antagonists of AT-1 receptors show an in vitro antioxi-
dant effect against the hypertonic glucose-derived oxidative stress.nosis. Results: Group II and III showed significantly increased intersti-
tial space (24.1%, 28.6%) compared to Group I (15.5%) (P , 0,001).
Hypertension does not increase interstitial space in GN group, but it
Does spring-driven biopsy gun reduce the incidence of percutaneousdoes so in the ischemic group. Patients with renal failure have the
renal biopsy complications? F.J. Gainza, J.I. Minguela, M.L. Mun´iz,largest interstitial space (35,6% in Group III and 30.4% in Group II).
M.P. Martinez, J.I. Lopez-Vidaur, J.M. Urbizu, and R. Mun´iz, Nephrol-Renal function (measured as plasma creatinine and Crc) correlated
ogy and Radiodiagnostic Departments, Hospital de Cruces, Barakaldo-statistically with interstitial space (P , 0.01). Conclusions: Hyperten-
Bizkaia, Basque Country, 48903 Spain. The goal of technical advancession is an important factor associated with interstitial fibrosis. Intersti-
in percutaneous renal biopsy (RB) is to improve safety and feasibilitytial volume correlates with renal function.
of this procedure. However, there are few studies comparing the in-
crease of complications between manual and automated systems. We
have evaluated 347 RB, studying prospectively the incidence of compli-Different response of murine and mesangial cells on the high glucose-
derived hydrogen peroxide production. A. Solı´s, L.M. Ruiz-Mun˜oz, cations. All biopsies were performed under real-time ultrasonography.
The automated-system group (136 RB) were performed by oneJ.M. Urbizu, I. Gimeno, and I. Lampreabe, Department of Nephrology,
Cruces Hospital, Basque Country University, Vizcaya, Spain. Introduc- nephrologist with a Biopty gun US guided, passing the needle through
a device attached to the transducer, and the manual RB (209) weretion: Oxidative stress is considered to play a role in the pathogenesis
of diabetic nephropathy. Objective: The hydrogen peroxide (H2O2) performed “free hand”, with a Tru-cut cooperating both nephrologist
and radiologist. The diameter of the needle was 16-gauge and 14-gauge,production by human murine mesangial cells exposed to 5.5 (basal
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respectively. Evaluation of complications was performed according to possible role for CFTR in ADPKD we determined the presence of
DF508 mutation in 150 individuals from 25 families with the PKD1clinical and laboratory parameters and by color-coded Duplex ultraso-
nography performed 24 hours after puncturing, following the monitor- form of ADPKD. PCR with primers specific for the DF508 mutation
was performed and a total of 6 DF508-carriers were found in 3 ADPKDing of vital signs along the 24 hours post-biopsy. Both groups were
similar regarding plasma albumin levels, (P 5 0.47), percentage of families. Analysis of clinical data in the DF508 group versus another
group of blood relatives without the mutation did not show differences.nephrotic syndrome diagnosis, ratio allograft-/native-kidneys (1.23 vs
1.18), frequency of hypertensive patients (35 vs 41%; P 5 0.14) or Sonographic findings did not differ significantly between both groups.
Renal handling of sodium, chloride and potassium did not differ sig-mean blood pressure at time of RB (102 6 14 mm Hg); but patients
who underwent RB with automated device presented a hematocrit 4% nificantly between both groups, and another group of healthy subjects.
higher and a percentage superior of males (P 5 0.0008) than the other
group. There were no differences in the incidence of hematomas: 7
cases with the gun and 13 with the Tru-cut (P 5 0.87) or in macroscopic ADPKD ADPKD 1 DF508 Control
hematuria (4% vs 8%, respectively; P 5 0.2). Nevertheless arteriove- (n 5 6) (n 5 6) (n 5 6)
nous fistula were significantly less frequent with the automated device
FEC1 (%) 0.99 6 0.15 0.95 6 0.07 0.90 6 0.10(2% vs 12%; P 5 0.009). The fall of hematocrit at 24 hours postbiopsy
FENa (%) 0.75 6 0.09 0.71 6 0.06 0.66 6 0.10was similar with both techniques (1.4 and 1.2%, respectively). No
FEK (%) 12.6 6 0.8 12.7 6 1.4 12.6 6 1.7patient of the automated group required surgery, but one patient was
readmitted because of pain in the puncturing place. In the manual
group two patients underwent surgery because of hemoperitoneum
These data indicate that the CFTR-mutation carrier status is probablyand another presented obstructive uropathy produced by clots, suffer-
not a factor that modulates ADPKD progression.ing from anuria for two days. It seems that automated renal biopsy
ultrasonography guided reduces the incidence of complications, espe-
cially arteriovenous fistula. We speculate that the high velocity of the
Reflux nephropathy: risk factors from childhood to adult life. L. Es-shot is less injurious than the manual one. However, there were some
differences between groups regarding demographic features and diam- pinosa, M. Navarro, S. Malaga, L. Garcia, A. Vallo, C. Loris, J.I.
eter of the needles. Magarin´os, and N. Gallego. The long term prognosis of 67 children
(40 ? and 37 /) with primary reflux nephropathy, 57 bilateral and 10
with a solitary kidney, has been evaluated. All of them were over 18
Clinical and molecular analysis of the autosomal dominant polycystic years in the final visit (21 6 4y). Renal scars were evaluated by IVP,
kidney disease (ADPKD). R. Peces, E. Coto, E. Gago, M. Ariza, A.S. Tc-DMSA and/or US according to Smellie and Goldrich classification.
Laures, F. Tejada, S. Sa´nz de Castro, M. Arias, C. Lo´pez Larrea, R. EGFR, BP, proteinuria and maximum urinary osmolarity were ana-
Marı´n, and J. Alvarez Grande, Servicios de Nefrologı´a y Gene´tica, lyzed at the initial visit and in the final study.
Hospital Central de Asturias, Oviedo, Hospital Valdecilla, Santander.
ADPKD is one of the most common human inherited diseases with
a frequency of about 1:1000, characterized by the development of Initial Puberty Final
multiple enlarging cysts in the kidneys and other organs. It accounts
Age (years) 4,31 6 3,8 15,7 6 4,6 21,8 6 4for approximately 10% of cases of end-stage renal disease in white
EGFR , 80 ml/min/1,73 71% 64% 78%patients. ADPKD exhibits considerable variability with respect to both
ESRD 3% 7% 28%its renal and extrarenal manifestations. Genetic heterogeneity is likely
Osmu , 800 mOsm/l 90% 85% 92%to account for at least some of these differences. Linkage studies have
Protu . 4 mg/m2/h 27% 48% 69%determined that there are at least three forms of ADPKD. PKD1,
HBP 22% 16% 21%which is the most common, maps to chromosome 16 p13.3. PKD2, which
affects most of the remaining families, maps to chromosome 4q13-23.
A small number of families have another form, which has not yet been
mapped. DNA analysis with polymorphisms intragenic or closely linked The renal risk factors for decrease of EGFR:
to the PKD-genes makes it possible to define asymptomatic carriers.
We examined 30 families from Asturias and Cantabria and performed
gene linkage analysis with tightly linked markers for ADPKD1 and RR p
ADPKD2 genes. Positive linkage to PKD1 was found in 24 of the 30
Protu (initial) 1,55 ,0,005families, 5 families had positive linkage to PKD2, and 1 family showed
Protu (puberty) 2,07 ,0,005negative linkage to the PKD1 and PKD2 loci. In a search for mutations
Protu (follow up) 4,52 ,0,001in the PKD1 gene in affected families we identified a C to A at codon
HBP (follow up) 1,28 NS4058. Analysis of patients from these families showed that the genetic
heterogeneity had a phenotypic correspondence, with a milder pheno-
type for the non-PKD1 forms, with arterial hypertension, cysts, and
We found a high correlation between final EGFR and EGFR at pubertyend stage renal disease developing less frequently and later in life.
(r 5 0,9). The patients with at least one kidney with grade 1 scar and
those with grade 2 or more have been compared:
Autosomal dominant polycystic kidney disease (ADPKD) and DF508
mutation at the cystic fibrosis transmembrane conductance regulator
gene. R. Peces, E. Coto, E. Gago, M. Ariza, A.S. Laures, F. Tejada, Grade 1 Grade 2,3,4 p
and J. Alvarez, Servicios de Nefrologı´a y Gene´tica, Hospital Central
CRF 44% 86% p , 0,005de Asturias, Oviedo. Cystic fibrosis (CF) is a multisystem autosomal
Protu (follow up) 50% 88% p , 0,005recessive disorder caused by mutations of the cystic fibrosis transmem-
H.B.P. 17% 41% NSbrane regulator (CFTR), a protein that regulates cyclic-AMP-mediated
chloride conductance at the apical membrane of secretory epithelia.
Mutations in the CFTR gene are common in many populations. In the
Conclusions: Reflux nephropathy is a progressive disease and protein-north of Spain 2% of the general population are heterozygous for the
uria is the most important risk’s factor for progression. The controlmutation DF508. Patients with ADPKD develop renal failure because
of UTIS and BP in this study couldn’t stop the progression to ESRDof multiple, slowly enlarging renal cysts. Progressive cyst enlargement
in 28% of the patients. Multicenter study from Nephrology Units ofis caused, at least partly, by fluid secretion into the cyst lumen, driven
the Children Hospital: La Paz (Madrid), Central de Asturias (Oviedo),by chloride secretion. Recent studies have provided evidence that
S. Joan de Deu (Barcelona), Cruces (Bilbao), Miguel Servet (Zara-chloride secretion into ADPKD cysts proceeds via CFTR chloride
channels in the apical membranes of cyst epithelial cells. To define a goza), Virgen de la Salud (Toledo) y Ramo´n y Cajal (Madrid). Spain.
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Acute renal failure (ARF) in elderly patients. F. Berisa, A. Gasco´n, We study the possible OS that can be produced during the hemodialysis
M.L. Mateo, and J.J. Belvis, S. Nephrology, General Hospital Obispo (HD) with cuprophan membranes of 1,2 m2 surface and in patients
Polanco, Teruel, Spain. According to the 1995 census, 5% male and on continuous ambulatory peritoneal dialysis (CAPD). Material: We
7.9% female persons in our province are over 80 years old. It is there- studied seven healthy people as a control group, 10 HD patients (aver-
fore an aged population largely surpassing the national average. ARF age HD time was 34 6 5 months), and 11 patients on CAPD (39 6
among this set of patients, which has hardly ever been surveyed, has 22 months). Methods: The MDA was measured in red blood cells and
been revised. During the last 106 months, up to April 1997, 107 ARF plasma of the three groups using the Stocks Dormandi technique; total
patients over 80 years of age have been treated. They reach 37.7% of glutathione (GS), oxidized glutathione (GSSG) and reduced glutathi-
the total number, 65 of them were male patients (85.2 6 4.0 years) one (GSH) by the Ellman technique. The Paglia technique was used
and 42 were female patients (84.4 6 4.4 years); 17 of them were ninety- to measure the GPX in red cells and plasma. Results: The MDA values
year-olds, and one of them was a centenarian. Ten of the patients were elevated in patients on HD and CAPD in comparison with the
suffered respiratory insufficiency, 11 neoplasm, 11 dementia and 12 control group. There were no significant differences between HD and
patients presented cardiovascular disorder; 16 patients had chronic CAPD groups. Red cell concentration of GPX in patients on HD is
renal failure, with basal creatinine ,3.5 mg/dl. Forty-six patients came significantly lower than in controls, but is higher than in CAPD group.
from the service of nephrology, 21 came from other medical services, Patients on CAPD show lower levels of erythrocyte and plasma GPX
36 from surgical services (P , 0.001), and only 4 patients came from in comparison with controls and HD patients. What could be indicated
intensive care units. 21.5% of the cases presented nonoliguric ARF, here is that in patients on CAPD an important and more extensive
56.6% were on oliguria and 22.4% were on anuria. The causes were: oxidative stress than those in HD is produced.
volume depletion in 53 patients, more frequent than in ARF younger
patients, 21.4% having reached acute tubular necrosis (ATN), sepsis
in 31, with ATN in 61.2%. Cardiovascular disorder in 10 patients, End stage renal disease (ESRD) patients: profile of excluded vs in-
obstructive in 9, myeloma in 3 and polytraumatism in 1. 27 patients cluded patients on renal replacement therapy. R. A´lvarez, F. Ortega,
had undergone surgical operation. The request for hemodialysis (HD) P. Rebollo, J. Baltar, C. Dı´az Corte, F. A´lvarez-Ude, X. Badı´a, and J.was much lower than in the group ,80 years of age (P , 0.001), as A´lvarez Grande, Hospital Central de Asturias, Instituto “Reina Sofı´a”only 12 patients required dialysis, of which 7 were dialyzed, the use de Investigacio´n Nefrolo´gica, Oviedo, Espan˜a. Introduction: Since theof dialysis being discarded in 5 patients. Of the younger patients, 28.2% beginning of the 80’s, no patient who needs replacement therapy whorequired HD. 24 patients died (22.4%), and no significant difference has a reasonable life perspective, is excluded from end-stage renalwas found with the group ,80 years of age. Five patients had already
disease replacement therapy (RRT). However, most Nephrology Unitsrecovered renal function. 4 of the patients on dialysis died. The most
have implicit exclusion criteria. Objective: To compare profiles of RRTcommon cause of death was sepsis of abdominal origin in operated
included and excluded patients at a regional reference unit. Materialpatients. Conclusions: 1.- ARF is much more frequent in patients over
and Methods: Studied sample included patients who were started on80 years of age, mainly in male patients. 2.- The lower demand of
RRT, as well as excluded patients. The study had one year (1996)HD may be explained by a higher number of prerenal etiology cases
duration, and analysed parameters were: age, sex, living conditions,together with the fact that the patients who die without requiring HD
main diagnostic, simplified functional status index (Karnofsky), totaldie in a very short period, 3.1 6 1.8 days after start of ARF. 3.- No
concomitant disease index. Results: 15 patients were excluded fromdifference is found with respect to death rate.
RRT (group 1) and 33 patients were included (68.7%) (group 2). Main
differences were:
What is the profile of the antioxidant systems in chronic renal failure
(CRF)? M.C. Martı´n Mateo, S. Iglesias, A. de Paula, J. Bustamante, J.
Nun˜ez, A. Mendiluce, J. Herruzo, and J. Martin, Dpto. Bioquı´mica, Sex Age FS1 FS2 FS3 Comorb Card. C Insanity
Facultad de Ciencias, Universidad de Valladolid, Servicios de Nefrologı´a
group 1 60% v 69.1 40% 53% 7% 12.46 73% 33%del Hospital Universitario y Hospital Pio del Rio Hortega, Valladolid,
group 2 60.6% 60.7 0% 49% 51% 4.63 21% 0%Spain. Erythrocytes are the more vulnerable cells to the attack from
p NS NS ,0.005 ,0.005 ,0.005 ,0.005free radicals (FR), since about 3% of the oxyhemoglobin changes daily
to methemoglobin. Cells contain protective enzymes which catalize FS 5 Functional status (Karnofsky); 1 (0–44); 2 (45–79); 3 (80–100).
the FR degradation or inactivation. A few of these are glutathione Card. C 5 Cardiac comorbidity.
peroxidase (GPX), glutathione reductase (GRED), and glutathione S
transferase (GST). At cell level small molecules such as total glutathi-
Diab Intersone (GS), oxidized glutathione (GSSG), and reduced glutathione
Nephrosc M N Glomer polycyst Mielom Others Support(GSH) appear and act as trash collectors of FR. In CRF an imbalance
in the oxidant-antioxidant state is produced making these patients
Group 1 33.3% 13.3% 6.7% 0% 0% 1.3% 26.7% 27% Nomore susceptible to FR attack. Material: To obtain a profile of the
Group 2 9.1% 12.1% 21.2% 21.2% 6.1% 0% 30.3% Allantioxidant state in CRF, a group of 20 CRF patients with creatinine
p ,0.05 ,0.005clearance between 7,16–14,03 ml/min has been used, against a control
group of 15 healthy people. Methods: For both groups the erythrocyte
concentrations of the following were determined: GS, GSST and GSH
Conclusions: 1) Not included patients represent 31.3% of the total.by Ellman’s method, GPX activity by Paglia’s method, GRED and
2) Their profile, with respect to included patients, has the followingGST by Habig’s method and hemoglobin by cyanomethemoglobin.
characteristics: a) no sex difference; b) worse functional status; c)Results: GSH/GSSG coefficient is lower in CRF patients than in the
higher mean age; d) worse living conditions; e) higher nephrosclerosiscontrol group, which indicates that CRF patients are more vulnerable
incidence in excluded patients and higher glomerulonephritis incidenceto the FR attack. There seems to be a relation between GPX activity
in included patients, same diabetes mellitus incidence; f) higher comor-and creatinine clearance. GRED activity is lowered, which could indi-
bidity index at the expense of cardiac pathology and insanity.cate a possible alteration of the pentoses pathway in these patients.
GPX activity is likewise low in CRD patients erythrocytes, indicating
a deficit in some antioxidant systems.
Evolution of socio-demographic and clinical characteristics in elderly
patients who were started on end-stage renal disease renal replacement
therapy (RRT) from 1985 to 1994. J. Baltar, F. Ortega, P. Rebollo,Does the dialysis modality modify the oxidative stress in patients on
C. Dı´az Corte, R. A´lvarez, F. A´lvarez-Ude, X. Badı´a, J. Guederiaga,dialysis? M.C. Martı´n Mateo, E. del Canto, M. Barrero, J. Bustamante,
A. Diaz Fonseca, M. Gorostidi, C. Mejido, P. Escalada, M. Ban˜os, andN.S. Jabari, A. Mendiluce, J. Martı´n, and J. Herruzo, Dpto. Bioquı´mica,
J. A´lvarez Grande, Hospital Central de Asturias, Instituto “Reina Sofı´a”Facultad de Ciencias, Universidad de Valladolid, Servicio de Nefrologı´a,
de Investigacio´n Nefrolo´gica, Oviedo, Espan˜a. Introduction: Mean ageHospital Universitario, Valladolid, Spain. An index of the oxidative
of patients who start RRT is higher every time. This study was designedstress (OS) is deduced from the ratio between malonil-dialdehido acid
to analyze elderly patients’ (.65 years) characteristics. Material and(MDA) and glutation peroxidasa (GPX); the MDA is a significant
Methods: 157 (33.5%) elderly patients were retrospectively studied,index of the lipid cell membrane peroxidation by oxygen free radicals
(FR). Otherwise GPX acts, even as other enzymes, like an antioxidant. out of a total number of 468 patients that were started on TRS in our
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region, during the decade 1985–1994, with respect to the following Changes in hospital admittances at third level nephrology units during
the last decade. J. Baltar, F. Ortega, C. Dı´az Corte, R. A´lvarez, and J.variables: sex, marital status, main diagnostic, functional status index,
transplant, total concomitant disease, hemoglobin, hematocrite, urea, A´lvarez Grande, Servicio de Nefrologı´a, Hospital Central de Asturias,
Oviedo, Espan˜a, Instituto “Reina Sofı´a” de Investigacio´n Nefrolo´gica.creatinine, total proteins and albumin. Results:
Introduction: During the last decade there have been important socio-
economic and health changes in Spain, which could be reflected in
the type of hospital admittances at a Nephrology unit. Objective: ToMain diagnostic N (%) Func. Condition Index
compare the activity of a Nephrology Unit during the two-year periods
1 2 3 of 1985–86 and 1995–96 at a third level hospital. Material and methods:
NA* DM GN* NI PQ others worse average better Studied variables were socio-demographic aspects (age, sex, geographic
origin), hospital stay, diagnosis and diagnosis procedures (renal biops-,65 38 (12) 59 (19) 77 (25) 35 (11) 32 (10) 70 (23) 9 (3) 90 (30) 201 (67)
ies, arteriographies, etc.), as well as mortality rate in patients admitted.65 40 (26) 35 (22) 17 (11) 17 (11) 10 (6) 38 (24) 10 (7) 60 (40) 79 (53)
in our service during these years. Results: Number of admittancesp *p , 0.0005 p , 0.01
increased from 629 to 963 patients, with a short predominance of males
Sex Transplant Total concom. disease Creatinine in both periods (61 and 56%, respectively). Average age, which was
around 52 years during the period 1985–86, showed an important in-
Male Female No Yes 0 1–3 .4 ,12 >12 crease, exceeding 59 years in 1996. Mortality rate remained invariable,
approximately 5.5%. Average stay increased from 10.3 to 11.8 days.,65 204 (66) 107 (34) 161 150 89 (30) 135 (45) 78 (26) 188 (69) 85 (31)
Causes for hospital admittance experimented statistically significant.65 84 (54) 73 (46) 154 3 15 (10) 77 (51) 58 (39) 112 (86) 18 (14)
changes: acute renal failure was reduced by a half, and hypertensionp p , 0.05 p , 0.00001 p , 0.00001 p , 0.0005
by two thirds; number of patients presenting chronic renal disease and
percentage of patients with glomerulonephritis (all histological forms
decreased, except for segmentary and focal Hyalinosis* and rapidlyConclusions: 1) Male predominance only occurs in patients under 65
progressive forms with extracapillar proliferation which, in addition,years. There are no sex differences in elderly patients. 2) Nephroangio-
became the most frequent) also decreased, and, on the other hand,sclerosis diagnostic prevailed in elderly patients and glomerulonephritis
number of patients admitted on periodical Hemodialysis program in-diagnostic in patients below 65. The remaining diagnostics do not
creased, several patients presenting vascular access problems, and,present significative differences. 3) Elderly patients had worse func-
above all, the number of admitted patients for renal transplant in-tional status indexes and more concomitant diseases at the moment
creased from 10.9% to 35%. Forty-nine renal biopsies were obtainedof inclusion on program, than younger patients. 4) Transplants are
during the first two-year period, and 46 during the second. The numberalmost exclusively carried out in young patients (only 1.91% elderly
of admitted renal patients from zones with no available nephrologistspatients received a transplant). 5) With respect to analytic parameters,
is 1.55 per 1,000 inhabitants, in contrast with 0.55/1,000 inhabitantsonly plasmatic creatinine, three months after beginning of RRT,
from zones where nephrologists are available. Conclusions: 1) Increaseshowed a significative difference between young and elderly patients.
of number of admittances due to growth of transplanted population
and on HD. 2) A slight predominance of males persists. 3) Important
mean age increase. 4) Mean stay increase. 5) No variation of annualChanges in socio-demographic and clinical characteristics of patients
death rate. 6) Renal transplant admittances increase. 7) Number ofadmitted on end-stage renal disease replacement therapy (RRT) from
patients in HD increase. 8) Clear decrease of HTA admittances. 9)1985 to 1994. J. Baltar, F. Ortega, P. Rebollo, C. Dı´az Corte, F. A´lvarez-
Stable number of biopsies at the expense of those of transplanted pts.,Ude, X. Badı´a, R. A´lvarez, J. Guederiaga, A. Diaz Fonseca, M. Goros-
but with a significative percentage difference. 10) At the moment, thetidi, C. Mejido, P. Escalada, M. Ban˜os, and J. A´lvarez Grande, Hospital
most frequent GN’s are the rapidly progressive ones. 11) AdmittancesCentral de Asturias, Instituto “Reina Sofı´a” de Investigacio´n Nefrolo´g-
from health zones without nephrologist show a significant increase.ica, Oviedo, Espan˜a. Introduction: Since the beginning of the 80’s, no
patient who needs RRT and has a reasonable life perspective, is ex-
cluded from it; this fact, together with other conditions, have produced
Destructive antioxidant activity, superoxide dismutase (SOD) and cat-changes in patient’s characteristics during the last decade. Objectives:
alase (CAT), on hemodialysis (HD) and continuous ambulatory perito-To study changes that occurred during a decade in patients that started
neal dialysis. M.C. Martı´n Mateo, A. Herna´ndez, A. de Paula, J. Busta-RRT. Material and Methods: A retrospective sample of 468 patients
mante, A. Mendiluce, N.S. Jabary, J. Martı´n, J. Herruzo, and C.(over 80% of the region’s patients) was divided into two groups, ac-
Este´banez, Dpto. Bioquı´mica, Facultad de Ciencias, Universidad decording to the year of replacement therapy initiation: a) 1985–1989 and
Valladolid, Servicios de Nefrologı´a del Hospital Universitario y Hospitalb) 1990–1994. Significative differences were analysed for the following Pio del Rio Hortega, Valladolid, Spain. Oxygen free radicals are neu-socio-demographic and clinical variables: number of patients who tralized by the antioxidant systems, preventive and destructive., Thestarted therapy, age at start, frequency of elderly patients, sex, main enzymes SOD and CAT belong to these systems. We study the antioxi-diagnostic, functional status index, comorbidity index, transplant, he- dant effect of these two enzymes on HD and CAPD. Material: Wemoglobin, hematocrite, urea, creatinine, total proteins and albumin. study seven healthy people (age 28 6 8 years) as control group, tenResults: patients (age 59 6 16 years) on HD 12 hours weekly with 1,3 m2
poliacrilonitrilo membranes, six patients (age 64 6 5 years) on HD 12
hours weekly with 1,3 m2 cuprophan membranes, and eleven patients
Creati- (age 57 6 5 years) on CAPD. Time on dialysis was more than 2 years
Age at Trans- nine for all groups. Methods: The SOD was measured by Paoletti Mocali’s
start Main diagnostic plant (mg/dl) method, the CAT by Aebi’s method. These determinations were effec-
tuated before and after HD, and during the CAPD. Results: The SOD,65 .65 NA* DM GN* NI PQ* others No Yes ,12 .12
values were not modificated in the patients on HD with cuprophan
a 145 47 22 35 47 27 25 36 117 75 103 57 membranes in relation to the control group. There are no differences
76% 24% 11% 18% 24% 14% 13% 20% 61% 39% 64% 36% in SOD activity after and before HD. In the patients on HD with
b 166 110 56 59 47 25 17 72 198 78 197 46 poliacrylonitrilo, the SOD values were lowered and showed significant
60% 40% 20% 21% 17% 9% 6% 27% 72% 28% 81% 19% differences (P , 0.001) in comparison with the controls. This lowering
p ,0.001 *,0.005 ,0.05 ,0.001 was more intense at the beginning of HD. There was a significant
elevation (P , 0.001) in patients on CAPD in comparison with controls
and patients on HD. The CAT on the HD with cuprophan (before
Conclusions: There has been an increase of elderly patients, patients and after HD), was significantly higher (P , 0.001) than in controls.
with nephroangiosclerosis, and diabetic patients during the last five There were not significant differences between HD with poliacryloni-
trilo (before and after HD) and controls. The patients on CAPDyears; and a decrease of patients with glomerulonephritis percentage,
number of patients with polycystosis and plasmatic creatinine level. No showed a significant elevation (P , 0.001) in comparison with the
control group, although this elevation is lower than in the patients onsignificative differences were found for the remaining studied variables.
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HD with cuprophan. These findings could suggest that the patients on Conclusions: Peritoneal calcium balances are always negative when
HD with cuprophan and patients on CAPD have more destructive using dialysis solutions with 4, 5 and 6 mg/dl calcium concentration,
antioxidant activity than the patients on HD with poliacrylonitrilo. that is, the patient loses calcium. The lower calcium concentration, the
greater peritoneal calcium loss, greater serum calcium decrease and
more PTH secretion. This chronic stimulus of PTH, if not compensated
Factors that influence peritoneal calcium balances. I. Moina, J. Monte- with oral calcium, can lead to secondary hyperparathyroidism. Calcium
negro, R. Saracho, I. Martı´nez, and J. Ocharan, Nephrology Unit, Hospi- concentration in peritoneal dialysis solutions must be individual, de-
tal de Galdakao, Bizkaia, Basque Country, Spain. Peritoneal calcium pending on the ultrafiltration rate, serum Ca11, peritoneal calcium
balances (PCB) are influenced primarily by serum Ca11, ultrafiltration balance, and the needs of oral calcium carbonate and calcitriol. When
rate and Calcium concentration in dialysis solutions. Even taking into using low calcium solutions will be necessary to watch PTH levels.
account these three factors, sometimes the obtained results are very
different. In order to ascertain whether other factors are influencing,
we have analysed the following variables: type of buffer (bicarbonate/
Peritoneal losses of lipoproteins in continuous ambulatory peritoneallactate), timing of the exchanges, dwelling time, glucose and albumin
dialysis. M.P. Pe´rez del Barrio, V. Pe´rez Ban˜asco, F.J. Borrego Utiel,concentration in the effluent and measured calcium type (ionized or
J.M. Arias de Saavedra (*), P. Serrano Angeles, S. Garcı´a Marcos, J.total). We took 8 stable patients on CAPD, and performed PCB follow-
Borrego Hinojosa, M.J. Garcı´a Corte´s, A. Lie´bana Can˜ada, and M.C.ing standard formulae, measuring albumin, glucose, ionized and total
Sa´nchez Perales, S. de Nefrologı´a y Bioquı´mica (*). H.G.E. “Ciudadcalcium in blood and in every drained bag. The buffer type and timing
de Jae´n”, Jae´n, Spain. Introduction. The presence of serum lipids ab-of the exchanges did not influence in PCB (P . 0.05). Glucose concen-
normalities in continuous ambulatory peritoneal dialysis (CAPD) pa-tration in drained dialysate influenced in a negative way (P 5 0.0001).
tients is common, however there are few studies about what occursPeritoneal dwelling time correlated positively with PCB (P 5 0.04).
in peritoneal fluid levels. We proposed to analyze the presence ofAlbumin concentration in effluent did correlate with total calcium but
lipoproteins in peritoneal fluid and its relationship to some demo-not with ionized calcium (P . 0.05).
graphic factors and biochemical parameters. Patients and methods.
We included in the study the 32 patients in CAPD treatment at the
moment of accomplishing the same: 13 male (41%) and 19 female
(59%). Eight (25%) were diabetics; 24 (75%) were hypertensive pa-
tients and 12 (37.5%) obese. The mean age was 59 6 13 (28–82) years
with 37 6 44 (3–186) months in peritoneal dialysis. We quantified:
glucose, urea, creatinine and lipoproteins in blood and in peritoneal
effluent. The effluents were collected following an overnight 8-hours
dwell. Results.
Sangre Liq. Perit. Saturacio´n Aclaram.
(ng;dl) (mg/dl) % (ml/min)
Glucosa 124 6 36 — — 70.0 6 27.1
Urea 132 6 44 130 6 49 94.9 6 16.5 3.60 6 0.78Conclusions: 1) In addition to the three recognized factors, there are
Creatinina 10 6 3 8.9 6 3.2 87.4 6 19.5 3.32 6 0.85also other factors that have influence in PCB. 2) Glucose concentration
Colesterol total 217 6 53 1.7 6 1.5 0.9 6 0.7 0.03 6 0.02and dwelling time have an influence on PCB in an indirect way, through
Triglice´ridos 180 6 62 13.4 6 4.6 8.1 6 4.0 0.03 6 0.14their relation with ultrafiltration. 3) It is important what type of calcium
Apo A1 97 6 12 1.2 6 0.7 1.2 6 0.7 0.04 6 0.03we measure in the effluent: if we measure ionized calcium, we do not
Apo B 97 6 26 0.3 6 0.3 0.4 6 0.4 0.01 6 0.01take into account the calcium bound to albumin, bicarbonate and other
Lp (a) 42 6 22 0.5 6 0.3 1.6 6 1.5 0.06 6 0.05anions, so we commit an error in calcium balance that may be more
Prot. Tot. (g/dl) 6.4 6 0.5 0.1 6 0.03 1.9 6 0.6 0.07 6 0.02than 1 mg/dl. In order to prevent this, all we have to do is to measure
Albu´mina (g/dl) 3.8 6 0.5 0.08 6 0.02 2.2 6 0.7 0.08 6 0.03total calcium in the effluent.
Serum PTH and peritoneal calcium balances. J. Montenegro, I. Moina, We observed that the peritoneal losses of lipoproteins were very de-
I. Martı´nez, J. Ocharan, and R. Saracho, Nephrology Unit, Hospital de creased. We did not find relations with age, sex, time in CAPD, diabe-
Galdakao, Bizkaia, Basque Country, Spain. CAPD patients frequently tes, hypertension or obesity. Antihypertensive drug therapy had no
present low or normal PTH levels due, to a large extent, to calcium influence in lipoprotein losses, neither the number of hypertonic dialy-
absorption through the peritoneum when using 7 mg/dl dialysis solu- sate bags used. There was no relationship to the clearance of glucose,
tions. In order to observe PTH changes when using dialysis solutions creatinine or urea. There was good positive correlation between the
with a lower calcium concentration, we studied 13 patients that persis- clearance of the lipids and the clearance of the different lipoproteins.
tently maintained normal PTH levels. These patients, during 15 days, Conclusions. The peritoneal lipoprotein losses are decreased in com-
got dialyzed with 4, 5 and 6 mg/dl calcium concentrations in different parison with urea, creatinine, albumin or total protein losses; we do
periods of the study, maintaining the same treatment and dialysis not find correlation with other factors such as age, sex, time in CAPD,regime. Studied parameters were: ionized Ca, total Ca, P, serum PTH diabetes, obesity, hypertension or antihypertensive drug therapy; nei-and total Ca in every drained bag in 24 hours. Peritoneal calcium
ther are there relations with blood levels of lipoproteins and otherbalances were calculated with standard formulae. These parameters
analyzed solutes. The peritoneal solute losses seem to depend only onwere studied before and 15 days after changing calcium concentration
molecular weight of the particles.in the dialysis solutions. Results: PTH levels before the change in the
calcium concentration were lower than 60 pg/ml (lower limit of the
normal value).
AN-69 membrane treated with polycathionic agents: effects on hyper-
sensitivity reactions, solute clearances, anticoagulation and thrombo-
genicity. J. Garcia-Valdecasas, M. Manjon, J.G. Hervas, M.J. Espigares,
M.D. Prados, A. Gallardo, J. Molina, M.T. Alvarez, and S. Cerezo,
[Ca] 7 mg/dl [Ca] 6 mg/dl [Ca] 5 mg/dl [Ca] 4 mg/dl Hospital Clinico Universitario, Granada. A polycathionic agent (poly-
ethyl-amine) was added for the inhibition of the activation of the
PCB mg/day 23 6 9 236 6 12 273 6 15 263 6 13 contact phase of AN-69 membrane, and anti-Xa factor, 1 & 2 fragments
Serum Ca11 mg/dl 51 6 0.2 5 6 0.1 4.7 6 0.2 4.6 6 0.1 of prothrombin were determined at 10 and 180 minutes of 42 HD
UF ml/day 1138 1306 1101 1204 sessions in 7 patients. Small solute clearances (Clurea, ClCr, Cluric acid andPTH rise pg/ml 50 113 223 Clphoshates) were also tested at times 30 and 180 minutes (Qb 5 350, Qd 5
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500 ml/min), comparing untreated (Crystal 2800 and 4000) vs treated HDF-HF on-line (P , 0.01), except for B2-microglobuline which low-
ered 50% with HDF-HF. Sequential elimination of the studied solutesdialyzers (Crystal 2800X and 4000X). No heparine at priming and
rinsing saline solution, but anticoagulation during HD session was shows a high parallelism (ns) except for B2 microlobuline (P , 0.005),
indicating that intra-extracellular change does not diminish the efficacywith Na heparine or low molecular weight heparine with usual doses.
Follow-up of 1000 dialysis at 22 patients to evaluate acute hypersensitiv- of high efficiency HD. Our results show the same elimination of solutes
with short td (100–110 min) using on-line HDF-HF than those obtainedity reactions (RH-SI) as well as coagulation phenomena (CF) scored
as reference from 1 to 5, at patients with and without IECAs treatment with standard HD (4 h). Sequential elimination shows that solute
extraction is diminished by both techniques, higher at greater K (15%(5 vs 17 patients respectively).
vs 20% at HDF-HF), as well as a parallelism between all solutes,
without differences mainly at intracellular ones (phosphorus). This
finding allows us to express the efficacy and security of short techniquesCrystal anti-Xa 112 Prot F-C score RH-SI
for the control of HD patients.
2800 0.66/0.34 6.0/14.0 3.1 2.1%
2800X 0.74/0.33 5.9/10.5 3.3 No
4000 0.91/0.56 6.2/23.6 3.0 3.4% HCR transmission through dialysate. J. Garcia-Valdecasas, I. Lopez,
4000X 0.79/0.56 4.7/23.6* 3.6* No F. Garcia Jr, F. Garcia, M.C. Bernal, A. Navas-Parejo, M.J. Espigares,
A. Gallardo, and S. Cerezo, Hospital Clinico Universitario, Granada.Crystal Clurea ClCr Cluric acid Clphos
The high incidence of seroconversions among patients sharing HD
2800 211/201 169/163 131/127 154/142 machines justifies the isolation of positive patients at different ones,
2800X 218/210** 175/166** 138/128** 163/155*** and there is no doubt about the nosocomial character of this infection
4000 258/246 203/195 154/144 185/178 at HD units. To investigate the possibility that HCV can cross the
4000X 260/252 208/200* 156/149** 193/187* dialysis membrane, we have studied 16 ultrafiltrates from 8 positive
HCV-RNA patients; 4 patients were dialyzed with cuprophan mem-*p , 0.05 **p , 0.01 ***p , 0.001
branes (Renak 1.3), 4 with poly-methyl-metacrylate (PMM, Filtrizer
B2-1.2 H) and 8 with polysulphone HF (PS, F-80), dialyzing with
Results show that the addition of this poly-cathionic agent does not transmembrane pressures (TMP) of 1100 mm Hg (8 sessions) and
inhibit the clearance of small molecules (even with an increase in 1400 mm Hg (8 sessions). HCV-RNA at the ultrafiltrate was positive
negatively charged molecules), does not alternate anticoagulation and/ at 6/16 (37.5%) cases, 5 with TMP of 1400 (62.5%) and 1 with TMP 5
or thrombogenicity, and eliminates hypersensitivity reactions due to 100 (12.5%). Related to the membrane, 4/8 (50%) cases were positive
with PS (75% for TMP 5 400 and 25% for TMP 5 100), and 1/4negative charges on the dialyzer surface, at patients with or without
IECAs administrated. (25%) for cuprophan and PMM membranes respectively, always with
a TMP 5 400. We conclude that HCV can be transmitted through the
dialysis membrane, so the dialysate must be considered as infectious,
which needs to be considered among the preventive measures encour-On-line measurement at real time of dialysis quantification. Diascan
aged to diminish nosocomial infection among HD patients.biosensor value. J. Garcia-Valdecasas, A. Navas-Parejo, M. Manjon,
C. Hornos, M.T. Varon, M.T. Alvarez, M. Garcia, A. Gallardo, and
S. Cerezo, Hospital Clinico Universitario, Granada. To evaluate the
accuracy of dialysis dose indicated by Diascan Biosensor through Na Epidemiological factors related with hepatitis G virus (HGV) infection
at haemodialyzed patients. J. Garcia-Valdecasas, I. Lopez, F. Garciatransference, dialysis liquid was collected with Quantispal at 18 dialysis
sessions belonging to 6 pts, testing for preHD urea levels (C1), 2 min Jr, F. Garcia, M. Manjon, M.C. Bernal, C. Hornos, M.C. Maroto, and
S. Cerezo, Hospital Clinico Universitario, Granada. HGV has recentlypostHD (C2), 35 min prior to dialysis end (C3) and dialysate (Cd).
Urea distribution volume [extracted urea-(delta*C3)/(C1-C3)] was been described as an aetiological agent that can produce viral hepatitis.
The aim of our study has been to evaluate the presence of HGV (through32.4 6 2.9 1, ns vs V Watson: 32.6 6 2.7 1, 49% corporal weight; Kurea
(extracted urea/Cm*td, Cm 5 C1-C3/Ln C1/C3) was 189 6 19 ml/min. HGV-RNA detection) and epidemiological factors involved (sex, age,
renal pathology, time on HD, transfusions, kidney transplantation,Depurated volume Kt was 41 6 3 1 ns vs Kt Diascan (40 6 5 1). Kt/
V (Quantispal) was 1.28 6 0.1, ns vs theoric Kt/V after rebound (1.28 6 HVB vaccination, HCV coinfection, ALT and other hepatic enzymes
elevation, among 70 hemodialyzed (HD) patients. The prevalence of0.1) and Kt/V Diascan (1.24 6 0.2). We conclude: 1 - Urea distribution
volume determined by Watson-Watson formulas do not show significa- HGV-RNA was 12.9% (9/70). No relation with sex (6/47 males vs 3/23
females, ns), age (59 years for positive patients vs 54 for negative),tive differences with real volume. 2 - Real Kt/V is the same as Kt/V
after rebound, with no significant differences with the Kt/V indicated renal pathology, time on HD (44 months for positive vs 56 for negative,
ns), transfusions (2/9 positive vs 33/61 negative, ns), renal transplanta-by Diascan, so the latter is a good indicator at real time of the dialysis
dose. tion or HBV vaccination. The coinfection with HCV was 19.2%, with-
out relation with ALT or other hepatic enzymes elevation. The pres-
ence of isolate HGV infection at HD patients does not alternate ALT
levels (14.3 IU for positive vs 14.7 IU for negative, ns). We concludeEfficacy of high flux on-line haemodiafiltration as short HD. Compari-
that HGV is present among HD patients (12.9% prevalence) withoutson with conventional HD. J. Garcia-Valdecasas, A. Navas-Parejo, J.G.
biochemical evidence and without relation with epidemiological factorsHervas, C. Hornos, A. Gallardo, M.T. Alvarez, A. Lopez, M. Lopez,
usually related to other hepathotropic viruses in these patients.and S. Cerezo, Hospital Clinico Universitario, Granada. High flux on-
line haemodiafiltration (HDF-HF on-line) has performed well as a
short dialysis technique (90–150 min.), with the control of uremic
solutes, hidroelectrolytic balance, acid-base, calcium-phosphorus and Anticoagulation with low-dose unfractionated heparin in continuous
renal replacement therapies: Coagulation parameters and filter lifeB2-microglobuline at long-term studies, when Kt/Vs higher than 1.1
are reached after urea rebound (1.4 without rebound). To evaluate if span. F.J. Gainza, J.I. Minguela, J.M. Urbizu, and I. Lampreabe, Ne-
phrology Department, Hospital de Cruces, Barakaldo-Bizkaia, Basqueit corresponds with an adequate extraction of solutes, weekly extraction
of urea, creatinine, uric acid, phosphates and B2-microglobuline, in Country, Spain E-48903. Continuous renal replacement therapies pro-
vide enormous advantages regarding hemodynamic stability and pro-dialysate collection (Quantispal) were studied at 8 patients, comparing
standard HD (PS-LF, F6, Qb 5 300, Qd 5 500 ml/min, td 4 h) with gressive cerebrovascular and cardiovascular adaptation in contrast to
the more rapid changes caused by intermittent hemodialysis. However,HDF-HF on-line (PS-HF, F80, Qb 5 600, Qd 5 800 ml/min, td ranging
90–150 min to reach Kt/Vr . 1.1) (HD values/session 5 week/3): the need for a continuous anticoagulation of the extracorporeal circuits
remains one of the major drawbacks of these techniques. With thestandard HD, urea 5 24504 6 803 mg, creat 5 1787 6 224 mg, uric
acid 5 658 6 62 mg, phosphates 5 1180 6 223 mg, eliminations reached aim of defining the rationale for the use of anticoagulation strategies we
review our experience over 350 filters in 51 patients under continuousat 100–110 min in HDF-HF, and B2-microglobuline 5 0 at standard
HD with LF membranes, and 168 6 32 mg at HDF-HF on line. HD hemodiafiltration, venovenous in 50 and arteriovenous in 4 (in three
both techniques were undertaken). Filters were AN69 poliacrilonytrileefficacy lowered 15% each 30 min with standard HD and 20% with
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plates of 0.5 to 0.6 m2 (Hospal). Standard anticoagulation was pre- Comparative study of two PTFE synthetic grafts as a vascular access
for haemodialysis (Diastatt versus Stretcht). Early complications andscribed with the administration of sodium heparin 20 mg (2,000 U)
one year follow-up. I. Blanes, J.L. Go´rriz,* A. Sancho,* F. Go´mez, A.into the “arterial” line followed by continuous infusion of 5 mg per
Avila,* I. Martinez, I. Crespo, E. Alcoy,* E. Ortiz, and L.M. Pallardo´*,hour. Doses were then titrated depending on laboratory parameters,
Departments of Nephrology* and Vascular Surgery, Hospital Dr. Peset,such as activate partial thromboplastin time (APTT) or platelet count
Valencia, Spain. Introduction: The liberalization of acceptance criteriaand clinical data (bleeding, filter duration, etc.). Filters were changed
for dialysis and the progressive increase of the elderly populationelectively every 48 hours. In 45 patients regional (without protamine)
overall have increased the number of elderly haemodialysis (HD)sodium heparin infusion was administered; three with systemic antico-
patients worldwide. This population often lacks an adequate vascularagulation; one with low-molecular weight heparin [Dalteparin (Frag-
access; the placement of PTFE synthetic grafts is common, requiringmint) 5,000 U every 12 hours] and in two patients no anticoagulation
a period of wound healing and incorporation of fibrous tissue beforewas used because of thrombocytopenia (less than 50,000 platelets per
use, a period typically lasting two to three weeks. Central transientmicroliter). The initial mean (6SD) dose was 4.8 (60.8) mg/h (mode:
catheters have to be inserted to perform haemodialysis during this5; median: 5). The first APTT value in the arterial line was 1.66 (6.97)
time. Recently, a new prosthesis has been available (PTFE Diastatt)times the control and in venous line 1.8 (6.97). The 75-percentile of
which permits early cannulation, even at 72 hours after the implanta-heparin dose during the treatment was 6 mg per hour, and the APTT
tion. Objective: To compare the results of two synthetic HD shunts1.51 (6.63) and 1.65 (6.66) times the control in arterial and venous
(PTFE Stretcht versus PTFE Diastatt) used as HD access, attendingline, respectively. There was a significative fall in the platelet count in to timing of puncture, early complications, and patency. Material and
the first 24 hours but a recovery was seen in the following days. The Methods: Prospective study. 86 synthetic grafts in 63 patients.
prothrombin time was 80 (617). A positive relationship between hepa-
rin dose and platelet count was present (r 5 0.43; P , 001). The global
average filter duration was 30.4 hours and the main cause of changing
PTFE Stretch PTFE Diastatwas filter and/or lines coagulation (44.2%) occurring at 22.7 (612)
n 5 37 n 5 49hours of working. No bleeding episode was directly attributed to the
patients 5 31 pat. 5 38technique. In conclusion, acceptable duration of filters was achieved
in the majority of cases with low-dose unfractionated heparin, rounding Sex (female/male) % 56/43 63/37
5 to 6 mg per hour (5,000–6,000 U), increasing the systemic APTT Mean age 6 SD (range), years 60 6 15 (20–85) 65 6 13 (21–80)
approximately 1.5 times the control. The heparin dosage was related to Previous vascular access, mean 6 SD 2.4 6 1.2 3.0 6 1.5
the platelet count and a transitory thrombocytopenia was usually present.
Results:
Follow-up of haemodialysis vascular access after treatment of central
venous lesions. A. Sancho, J.L. Go´rriz, I. Martinez,* I. Blanes,* A.
Avila, E. Alcoy, J. Martinez-Rodrigo, J. Palmero, and L.M. Pallardo´, PTFE Stretch PTFE Diastat p
Departments of Nephrology, Vascular Surgery* and Radiology, Hospi-
Timing of cannulation, mean days 20 (13–30) 5,2 (4–8) 60.001tal Dr Peset, Valencia, Spain. Introduction: The progressive increase
Complications:in the age of patients starting haemodialysis (HD) leads to difficulties
- postoperative hematomas 11% 12%to achieve an adequate vascular access. In several cases transient central
- wound infection 5% 0%venous catheters have to be inserted, that produce stenosis and throm-
- trombectomy 16% 12%bosis. These lesions produce disabling clinical manifestations of venous
-angioplasty 8% 6%hypertension as upper extremity edema and collateral circulation that
Primary patency (6 months, 1 year:) 72%–45% 63%–27% p 5 0.19makes difficult an adequate HD treatment. Endoluminal treatment of
Secondary patency (6 mo, 1 year:) 75%–59% 67%–34% p 5 0.06the lesions can prolong or even preserve these vascular access. Objec-
tive: The study was designed to evaluate the efficacy of precutaneous
endoluminal treatment of dysfunctioning vascular access (DVA) due to
Conclusions: PTFE Diastatt and PTFE Stretcht have been effectivecentral venous lesions (occlusions or stenose) proximals to the vascular
as vascular access for HD with no statistically significant differences,access. Material and Methods: From June 1993 to October 1996, 15
but PTFE Diastat allows early use, avoiding in most of the cases thepatients with DVA were treated (8 males, 7 females). DVA were 5
insertion of central venous catheters. As other vascular access, theyBrachiocephalic Brescia-Cimino fistulae (33%) and 10 PTFE Axillary-
fall short of the ideal for prolonged dialysis.Axillary grafts (67%). Mean age was 60 6 14 years, and 7 (47%) were
diabetics. DVA was manifested clinically by upper extremity edema
and collateral circulation in 9 cases (60%), and elevation of venous
Effect of administration of ranitidine on phosphorus binding capacitypressure in 6 (40%). All patients had previous history of ipsilateral
of calcium carbonate in hemodialysis patients. M.C. Sa´nchez Perales,subclavian catheter. After angiographic study, central venous detected
M.J. Garcı´a Corte´s, P. Serrano A´ngeles, F.J. Borrego Utiel, A. Lie´banalesions were 8 stenoses (53%) and 7 occlusions (47%). Twenty two
Can˜ada, J. Borrego Hinojosa, S. Garcı´a Marcos, P. Pe´rez del Barrio,procedures were performed in 15 patients, and they were 16 angioplas-
and V. Pe´rez Ban˜asco, Servicio de Nefrologı´a, Hospital General deties and in 6 patients angioplasty1tent prosthesis implant were per- Especialidades, Jae´n, Spain. Calcium carbonate is widely used in the
formed. Results: In the immediate follow-up one patient (6%) had treatment of uremic hyperphosphatemia. It is known for its solubility
thrombosis of the central venous lesion, and a new vascular access in high pH. Thus, its phosphate-binding capacity might be reduced by
was performed in the opposed arm. In the remaining 14 patients the rising gastric pH by H2-inhibitors, frequently used in Hemodialysis
treatment was successful. In the follow-up (21 6 10 months, range: patients. The Objective of this study was to evaluate the effect of
12–53), one patient received a kidney graft, 3 patients died (20%), 2 administration of Ranitidine on phosphate-binding capacity of Calcium
vascular access showed thrombosis (13%) and 9 remained permeable Carbonate in Hemodialysis patients. Patients and Methods: We studied
(60%), 5 of them requiring new angioplasties. Primary patency of the sixteen Hemodialysis patients selected on the basis of their satisfactory
vascular access after the treatment was of 86%, 46% and 40% at 1, 6 control of serum Phosphorus levels with Calcium Carbonate (6.93 6
and 12 months. Secondary patency (with needing of new angioplasties) 2.52 gr/d) without changing dose in at least two months and usual
was of 93%, 80% and 72% at 1, 6 and 12 months. Conclusion: Percuta- compliance to the treatment. 10 M/6FM. Mean age: 57 6 16 years.
neous endoluminal treatment of the central venous lesions in HD Time on Hemodialysis: 55.3 6 54.3 months. None of them had previous
patients with DVA can be effective preserving their permeability and Diabetes, Ulcus, severe Hyperparathyroidism nor Parathyroidectomy.
improving their symptoms. Pervious subclavian venous catheters is None had received H2-receptors antagonists, Omeprazole nor Calci-
probably the main cause related to the development of these lesions, triol. Patients received Ranitidine per os 150 mg every 12 h during
four weeks. Habitual dietary, Calcium Carbonate dose and Dialysisso its use should be avoided.
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(Time, Dialyzer, Dialysate Calcium) were not modified. Serum Cal- led to the increased acceptance of older patients in substitutive treat-
ment. We analyzed the differential aspects of this sector of the popula-cium, serum Phosphate and Alkaline Phosphatase were monitored
weekly during administration of Ranitidine and two weeks after stop- tion and the measures to improve the survival rate. Methods: A total
of 236 were studied, 71 of them (30%) are considered older patientsping Ranitidine treatment. PTH, Albumin and CO3H- were deter-
mined at the beginning and at the end of treatment with Ranitidine. (65 years or older). The period of surveillance is 23,7 6 16 months
(3–60 months). The characteristics of the substitutive treatment, theThe compliance to treatment was assessed through personal interview.
Results: All patients completed the study. comorbid factors and the evolution of the biochemical and nutritional
parameters were recorded. Results: The lowest survival rate of old
patients is recorded from the first year (81% vs 94% in those under
65, Log-Rank: P 5 0,03), and after 5 years it is 39% vs 68% (P 5Ranitidine PostRanitidine
Baseline 0,0004). We do not find statistically significant differences in the doses
P//Ca 18-P//Ca 28-P//Ca 38-P//Ca 48-P//Ca 18-P//Ca 28-P//Ca ANOVA of dialysis, total proteins, albumin, prealbumin, total lymphocytes cho-
lesterol and triglycerides. Age is negatively correlated with the fat5.0360.8 5.260.8 5.361.4 5.0361.05 4.861.03 5.0761.07 5.0261.2 NS
segment evaluated through the tricipital skinfold thickness (r 5 20,21;9.860.4 10.060.5 9.760.4 10.060.7 9.860.5 9.960.5 10.060.5 NS
P , 0,01), with somatic protein measured through the midarm musclePTH B//F (pg/ml): 155.86 6 125 189.34 6 158.65 t Student
circumference (r 5 20,20; P , 0,01) and plasmatic creatinin (r 5Albumin B//F (gr/dl): 4.38 6 0.30 4.49 6 0.25 NS
20,26; P , 0,01) and with the intake of proteins (r 5 20,26; P , 0,01)CO3H-B//F (mEq/l): 22.01 6 2.4 23.13 6 3.2
and calories (r 5 20,24; P , 0,01) evaluated through a diet survey.
P//Ca: Phosphate//Calcium (mg/dl); B: Baseline; F: Final Ranitidin Conclusions: 1) With the techniques available today, we can achieve
a satisfactory quality of dialysis in old patients. 2) The initial associated
pathology is not greater in this group, primarily due to the greaterConclusions: The administration of Ranitidine to chronic Hemodialysis
rigour in the selection for the start of chronic hemodialysis therapy.patients using Calcium Carbonate as phosphate binder led to no modi-
3) The nutritional state and the nutritional intake are especially defi-fications on the control of serum Phosphate. Serum Calcium, Bicarbon-
cient in this group and it is an important question in order to achieveate and PTH did not show significant changes.
a higher survival rate.
Management of renal osteodystrophy (ROD) in Spain. A multicentre
Metabolic markers of bone disease in a non-selected population ofinquiry. C. Dı´az-Corte, M.L. Naves, A. Rodriguez, S. Barreto, C. Go´-
7422 dialysis patients. C. Dı´az-Corte, M.L. Naves, A. Rodriguez, C.mez, A. Canteros, and J.B. Cannata (on behalf of the 171 collaborating
Go´mez, J.L. Ferna´ndez Martı´n, and J.B. Cannata (on behalf of the 171centres), Unidad de Metabolismo Oseo y Mineral, Instituto Reina Sofı´a
collaborating centres), Unidad de Metabolismo Oseo y Mineral, Institutode Investigacio´n, Hospital Central de Asturias, Oviedo, Spain. Preven-
Reina Sofı´a de Investigacio´n, Hospital Central de Asturias, Oviedo,tion, diagnostic and treatment criteria of ROD are in constant evolu-
Spain. Prevention, diagnostic and treatment criteria of renal osteodys-tion. We submitted a postal inquiry to all dialysis centres of our country,
trophy (ROD) are in constant evolution. We submitted a postal inquirycomprising 30 questions related to ROD management. The answers
to all dialysis centres of our country, comprising 30 questions relatedfrom 171 centres, 63% of the total registered (10724 patients) were
to ROD management. As part of the items we included the latestthen analyzed. In this abstract we summarize only the main results.
analytic data (Ca, P, iPTH and Al) of the patients. In this abstract weSerum levels considered ideal for dialysis patients: Ca between 10 and
present data concerning the response from 7422 dialysis patients (14710.5 mg/dL (53% of centres), between 9.5 and 10 mg/dL (28%), be-
centres). Ca: mean 9.7 6 0.9 mg/dL. In 23% of the patients serum Catween 10.5 and 11 mg/dL (14%) and between 9 and 9.5 mg/dL (5%
was lower or equal to 9 mg/dL; in 44% between 9 and 10 mg/dL; inof centres). P between 4.5 and 5.5 mg/dL (77% of centres), between
26% between 10 and 11 mg/dL and in 7% higher than 11 mg/dL. P:5.5 and 6.5 mg/dL (15%). iPTH: between 120 and 150 pg/mL (75%
mean 5.6 6 1.6 mg/dL. In 26% of patients serum P was lower or equalof centres) and between 60 and 120 (19%). Ca concentration used in
to 4.5 mg/dL; in 25% between 4.5 and 5.5 mg/dL; in 24% between 5.5the dialysis fluids: 44% of centres use 2.5 mEq/L, 28.5% use 3 mEq/L,
and 6.5 mg/dL and in 25% higher than 6.5 mg/dL. CaxP: mean 54.526% use 3.5 mEq/L and 2% of centres use 2 mEq/L. 49% of the centres
6 16.5. In 16% of the patients Ca-P product was higher than 70, thisdecrease Ca concentrations in the dialysis fluids when the patient is
percentage rose to 38% in the patients receiving vitamin D, in 23%receiving parenteral calcitriol. Vitamine D therapy: continuous oral
of the patients was higher than 65, rising 42% in patients receivingadministration is the modality of choice in 37% of the centres; oral
vitamin D. iPTH: mean 294 6 360 pg/mL. In 23% of patients serumpulse therapy is used in 38% and intravenous administration in the
iPTH was lower or equal to 60 pg/mL; in 18% between 60 and 120;remaining 25%. In 28% of the centres calcitriol pulse therapy is started
only in 22% between 120 and 250 (the ideal levels); in 20% betweenwhen iPTH is above 250 pg/mL; in 52% when iPTH is over 500 pg/
250 and 500, in 12% between 500 and 1000 and 5% of patients havemL and in 16% when values are greater than 750 pg/mL. Initial dose
iPTH higher than 1000 pg/mL. Al: mean 27.1 6 23.5 mg/L. In 50% ofis usually 1 mg three times/week when calcitriol is either orally or
patients serum Al was lower than 20 mg/L (the values accepted asparenterally administered (in 74% and in 77% of centres respectively).
adequate); in 42% values ranged between 20 and 60; 8% of patients hadCriteria of response to calcitriol therapy: 59% of centres consider
high serum Al (.60 mg/L). Vitamin D: 44% of patients was receivingresponse any decrease in PTH levels; in 24% a decrease at least of
calcitriol in any of its forms of administration (46% of hemodialysis20% from the basal level. 78% of the centres wait for 6 months before
patients and 31% of peritoneal dialysis patients). In summary, twoconsidering a patient as “non-responder patient.” Parathyroidectomy:
thirds of the patients in our sample had serum Ca values lower or80% of the centres only realize parathyroidectomy when iPTH is higher
equal to 10 mg/dL and, therefore, below the levels to suppress PTHthan 750 pg/mL (in 41% when iPTH is between 750 and 1000 and in
in dialysis. Only 25% of patients had serum P higher than 6.5 mg/dL.39% when iPTH is higher than 1000). There are a mean of three
In 41% of the patients serum iPTH was lower or equal to 120 pg/mL,parathyroidectomized patients in every dialysis centre (4.5% of the
in the range of levels found in low-bone turnover. Only in 50% of thetotal 10724 patients). The data collected from the inquiry show that
sample, Al levels could to be considered suitable (,20 mg/L).there are important variations in some of the aspects related to the
usual patient management at the different units in our country.
Mortality risk in hemodialysis: differences between type I and type II
diabetes. L.M. Lou, I. Garcı´a, A. Sanz, A. Blasco, R. Alvarez, F. Martı´n,The survival of older patients in hemodialysis: the importance of the
J. Pe´rez, and J. Cebollada, Departments of Nephrology and Nutrition,nutritional state. L.M. Lou, R. Alvarez, A. Sanz, I. Garcı´a, A. Blasco,
University Hospital (Zaragoza); Miguel Servet Hospital (Zaragoza);F. Martı´n, M. Azuara, and J.A. Gutie´rrez Colo´n, Departments of Ne-
and Alcan˜iz Hospital (Teruel), Spain. Introduction and objectives: Wephrology and Nutrition, Miguel Servet Hospital (Zaragoza); University
analyzed the differential characteristics of type I diabetes (DM I) andHospital (Zaragoza); and Alcan˜iz Hospital (Teruel), Spain. Introduc-
type II diabetes (DM II) and their influence on the mortality rate oftion and objectives: The increase in life expectancy in the general
population and the advances in the techniques of hemodialysis have patients in chronic hemodialysis treatment (HD). Methods: We include
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in the study 50 DM patients in HD, 18 DM I and 32 DM II. The period Conclusions: Rising gastric pH by H2-inhibitors led to lowering on the
of surveillance was 27 6 14 months (3–48 months). We record the age, Phosphate-binding efficacy of calcium carbonate. Serum calcium did
time on HD, comorbid factors, dialysis quality, biochemical determina- not show significant changes.
tions and nutritional evaluation. Results: The comparison of the differ-
ent variables is reflected in the table. Of the DM I patients, 9 (50%)
died and of the DM II patients 11 (34,3%) died, a difference statistically Functional study of early antigenic activation of peripheral blood (PB)
significant (Log-Rank P 5 0,044). cells in patients on hemodialysis (HD): the influence of nandrolone
decanoate (ND). A. Gasco´n, A. Orfao, J.J. Belvis, J. Ciudad, A. Lo´pez,
E. Iglesias, and F. Berisa, S. of Nephrology, Teruel; S. Cytometry,
DM I DM II P University of Salamanca, Spain. Lymphocyte preactivation described
in HD patients is associated with a higher level of CD25 activationAge (years) 45 67 ,0.001 antigen (Ag) and a lower capacity of both proliferating response andKt/V 1.1 1.0 NS production of IL-2. Previous studies have described a high level ofPCR 1.0 1.1 NS CD25 in T CD4 and CD8 PB lymphocytes in elderly HD patients,Comorbid factors score 6.3 5.3 NS which decreases significantly with ND as a treatment of anemia. CD25Body mass index 20.9 25.6 ,0.001 is an early activation Ag which appears 24 hours (h) after antigenicTricipital cutaneous fold 10.6 13.7 ,0.05 stimulation, and CD69 is a very early activation Ag which appears 4Arm muscle circumference 19.9 22.7 ,0.05 h after stimulation and disappears in 8 h. Nowadays, there are no dataAlbumin gr/dl 3.4 3.8 ,0.01 about the behaviour of CD69 in PB cells from HD patients. The aimCreatinine mg/dl 8.6 9.7 ,0.05 of the present study is to analyse, by three-colour flow cytometryProtein intake gr/Kg/dia 1.36 1.33 NS analysis, the level of Ag CD69 in T CD31/CD41, CD31/CD811,Caloric intake Kcal/Kg/dia 34.3 30.2 NS CD31/CD81 (Tgd) lymphocytes and in CD32/CD81 Natural KillerPeriod of survey (months) 25 28 NS PB cells. The functional study of cell activation by means of incubation
of PB samples during 4 hours at 378C with a monoclonal antibody is
carried out, opposite to CD2/CD2R antigens, which conditions theConclusions: 1) There are notable differences between DM I and DM
activation of lymphocytes expressing CD2. PB samples from 7 maleII, worse nutritional parameters in the former and greater age in the
elderly patients (68 6 3 years) on HD are studied, before starting thelatter. 2) The quality of HD and the comorbid factors is similar in
HD session, basally and after 4 months’ I.M. treatment with 200 mg/both groups. 3) The survival rate is lower in DM I despite their lower
week of ND. During the study period neither the performance norage. 4) The worse nutritional state would have influence on this lower
the HD membranes were altered. The results are expressed in percent-survival rate. 5) It would be suitable to consider, in the studies of
age of positive cells. Data of the functional study of cell activation arediabetic patients in HD, the important differences between the two
given between brackets.groups and to consider them separately.
Influence of gastric pH on the phosphate-binding efficacy of calcium CD691/31/41 CD69/31/811 CD691/31/81 CD691/32/81
carbonate. M.C. Sa´nchez Perales, M.J. Garcı´a Corte´s, F.J. Borrego
Basal 1,1 (36,8) 0,9 (12,9) 0,3 (10) 1,4 (5,6)Utiel, P. Serrano A´ngeles, J. Borrego Hinojosa, A. Lie´bana Can˜ada,
ND 14,4 (28,2) 3,1 (10,9) 0,8 (3,3) 2,2 (5,3)S. Garcı´a Marcos, P. Pe´rez del Barrio, and V. Pe´rez Ban˜asco, Servicio
de Nefrologı´a, Hospital General de Especialidades, Jae´n, Spain. Al- *P , 0.03 *P , 0.01 *P , 0.04
though in vitro studies have shown the greater solubility of calcium
carbonate in acid pH, it is not clarified if rising gastric pH may limit
the phosphate-binding capacity of calcium carbonate. The Objective ND induces a different immunomodulating effect at the level of CD69
of present study was to evaluate the effect of inhibiting gastric acid Ag as compared with what has already been described with CD25 and
secretion by H2-receptors antagonists on the phosphorus binding ca- HLA-DR Ags. Early activation is more intense in T CD41 lympho-
pacity of calcium carbonate. Patients and Methods: We studied seven cytes, although it is also increased in CD31/CD41. The lymphocyte
hemodialysis patients with acceptable control of serum phosphorus activation test also shows a general increase in cell activation, however
levels with calcium carbonate. Mean age 58,8 6 19 years; 4 M/3 FM. with a lower capacity of activation after ND treatment, above all in
time on hemodialysis: 38 6 49 months. None of them were taking H2- CD31/CD41 and weak CD31/CD81 cells. These results may be
inhibitors, omeprazole or calcitriol. They had no previous diabetes, related to inhibition of these cells to express CD69 after previousparathyroidectomy or severe hyperparathyroidism. They were studied activation conveying loss of its expression, or with lower level of preac-at midweek hemodialysis, previously to hemodialysis session, in three tivation already described in CD41/CD251 and CD81/CD251 lym-consecutive and randomized phases. Phase I: After fasting 10 h, 1.5
phocytes.gr of elemental phosphate oral was administered and then a standard
breakfast. Phase II: The same as phase I except that oral calcium
carbonate (1.5 gr of elemental calcium) preceded to administration of
Comparison between erythropoietin (EPO) and nandrolone decanoatephosphate. Phase III: The same as phase II but 300 mg of oral ranitidine
(ND) in elderly patients on hemodialysis: erythropoietic and nutritionalwas administered 10 and 1 h before beginning the study. In every
effects. A. Gasco´n, J.J. Belvis, E. Beser, A. Pe´rez, V. Rubio, and F.phase of study we determined serum calcium and serum phosphate at
Berisa, S. Nephrology, General Hospital Obispo Polanco, Teruel, Spain.baseline, 30, 60, 90, 120 and 180 minutes. Results:
ND has been used as a treatment (Tt.) of anemia in Hemodialysis
(HD) for years, until EPO was introduced. The increasing number of
elderly patients on HD in recent years, and the possible better response
of anemia to ND in these patients, has led us to study the influence
Area under curve of ND on the control of anemia and nutritional status in a group of
*Phosphate increment (%) (AUC) elderly patients on HD. Seven male patients on HD are studied (mean
age: 68 years), whose EPO is suspended 15 days before the start ofPhase 30 min. 60 min. 90 min. 120 min. 180 min. P Ca
ND Tt. Urologic control was performed previous to Tt. by means of
I 3.763.5 8.565.5 9.966.9 13.166.6 23.265.7 110.3650 29.3642 bimonthly digital rectal examination and levels of specific prostatic
II 20.366.2 4.0563.7 7.7626.2 9.665.2 16.867.1 64.9642 12.6656 antigen. The results are compared with the ones obtained in a control
III 20.665.7 5.3466.3 7.5567.5 15.8613.7 23.6612.1 91.4671 41.4649 group consisting of 12 patients on HD (10 F, 2 M; mean age: 71 years)
ANOVA ns P , 0.05 ns ns P , 0.05 P , 0.01 ns and on stable EPO Tt. Both groups, clinically stable and with suitable
dialysis parameters, are controlled for six months, with basal determi-* 60 min: I and II: P , 0.05; I and III: P , 0.05//180 min: I and II: P , 0.01; II
nation (M 0) and, every two months (M 2, M 4, M 6) the levels ofand III: P , 0.05 AUC Phosphate (mg.min.dl21): I and II: P , 0.01; II and III:
P , 0.05; I and III: ns hemoglobin, ferritin, transferrin, creatinine, total proteins, albumin,
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cholesterol, triglycerides and anthropometric parameters were studied: or oral calcium carbonate doses. Finally we used multivariate analysis
(multiple lineal regression and logistic regression) to investigate com-cutaneous tricipital fold (CTF), arm muscle circumference (AmC) and
body mass index (BMI). plex relations among KTV, age, sex, membranes and anthropometric
parameters but we did not find any significant association. We conclude
that malnutrition is a frequent problem in HD patients. We could
not find any association between adequacy of dialysis and degree ofPatients on Tt. with 200 mg/week I.M. of ND for six months: (* 5 p , 0.05)
malnutrition. Probably it is necessary to use a longitudinal design to
Month Hgb Ferri Trans Crea Prot Alb Cho TG CTF AmC BMI evidence this relation. Type of membrane and metabolic acidosis de-
gree do not seem to influence malnutrition appearance. Presence of
M0 10 189 176 8,9 6,6 3,8 215 156 11,1 25,4 25,7 hyperparathyroidism or anaemia does not associate with nutrition
M2 10,4 154 187 11,5 6,8 3,8 213 241 12,3 26,5 26,2 status.
M4 10,7 112 206 12,7 6,8 4,0 208 286 12,3 26,9 26,2
M6 11,4 128 218 12,2 6,9 3,8 213 224 12,8 26,7 26,2
* * * * * * * Alpha2-macroglobulin is better predictor of nutritional status than
albumin and prealbumin in stable haemodialysis patients. F.J. Borrego-
Utiel, C. Sa´nchez-Perales, M.J. Garcı´a-Corte´s, J. Chamorro (*), M.C.
Pe´rez-Miranda (**), J.M. Arias de Saavedra, S. Garcı´a-Marcos, A.Patients on EPO Tt. with 5000 U/week S.C. (range 3000–9000 U):
Lie´bana, and V. Pe´rez-Ban˜asco, S. de Nefrologı´a, Nutricio´n (*) y Bio-
Month Hgb Ferri Trans Crea Prot Alb Cho TG CTF AmC BMI quı´mica (**), Hospital General, Jae´n, Spain. The aim of this study was
to analyze the relation between serum protein levels and nutritionalM0 10,5 218 162 9,8 6,9 4 179 144 15,6 23,7 27
status in HD patients. We selected 70 stable patients, 44 Males (63%),M2 10,5 192 154 9,7 6,7 3,6 165 131 15,3 23,9 26,9
57 6 14 (21–81) years old and 57 6 47 (6–189) months in dialysis. NoneM4 10,9 153 178 9,8 6,8 3,9 173 144 14,9 23,8 26,5
was diabetic. All patients were dialyzed using bicarbonate as buffer, 47M6 10,8 159 162 9,4 6,6 3,4 174 133 15,1 23,5 26,5
(67%) with cellulosic and 23 (33%) with AN69 membranes. Nutritional
* status was based on measurements of anthropometric indexes (mid-arm
circumference or MAC, triceps, subscapular and abdominal skinfolds,
body weight and body mass index or BMI). We determined serumThese results show that ND may be a safe and efficient alternative to
albumin, prealbumin, retinol-binding protein (RBP), transferrin, ApoEPO in the Tt. of anemia in elderly male patients on HD, as not only
A1 and B, a1-antitrypsin (A1AT) and a2-macroglobulin (A2M). Pa-the levels of hemoglobin are improved, but also a better control of
tients were classified as malnourished if they presented reduction belowthe nutritional status is provided. Moreover, its use in undernourished
90% of reference value in one anthropometric parameter. We foundelderly males on HD may allow us to reduce the morbidity of these
65.7% patients with any degree of malnutrition: 61.4% with a lowpatients and improve their quality of life.
BMI, low MAC in 12.9%, low triceps skinfold in 12.9% and low
subscapular skinfold in 83%. No biochemical data were different be-
tween well and malnourished except for A2M (Welln. 141 6 39 vsNo direct association between adequacy of dialysis and nutritional
Maln. 174 6 56 mg/dl, P , 0.05). Malnourished patients were youngerstate in maintenance haemodialysis patients. F.J. Borrego-Utiel, M.J.
than wellnourished people (Maln. 53 6 15 vs Well. 66 6 7 years, P ,Garcı´a-Corte´s, C. Sa´nchez-Perales, J. Chamorro(*), A. Lie´bana, J. Bor-
0.05). Albumin was significantly correlated with age (r 5 20.32); preal-rego-Hinojosa, P. Serrano-Angeles, P. Pe´rez del Barrio, and V. Pe´rez-
bumin (r 5 0.56), RBP (r 5 0.57) and A1AT (r 5 20.51); prealbuminBan˜asco, Servicio de Nefrologı´a y Nutricio´n (*), Hospital General,
with RBP (r 5 0.80). A2M depended on gender (Male 153 6 48 vsJae´n, Spain. Several investigators have emphasized the importance of
Female 199 6 56 mg/dl, P , 0.01) and was correlated with time onadequacy of dialysis on nutritional state of haemodialysis patients. We
dialysis (r 5 0.30). Only A2M was significantly correlated (P , 0.01)selected 70 patients with stable clinical condition to investigate in a
with anthropometric indexes: weight (r 5 20.56), MAC (r 5 20.40),cross-sectional study the association between adequate dialysis and
subscapular skinfold (r 5 20.31) and BMI (r 5 20.37). When wenutrition. They were 44 males (63%), 57 6 14 (21–81) years old and
included A2M, sex, age and other serum proteins as predictors ofwith 57 6 47 months on dialysis. None was diabetic. All were dialyzed
anthropometric indexes in a multiple lineal regression analysis, weusing bicarbonate as buffer, 67% using cellulosic and 33% with NA69
found that A2M was always present in such equations (multiple r 5membranes. We evaluated anthropometric parameters like weight,
0.60–0.65), but not the rest of serum proteins. Logistic regression analy-body mass index (BMI), mid-arm circumference (MAC) and skinfold
sis also showed that sex, age and A2M were the best predictors of(triceps, subscapular and abdominal) thickness and we corrected them
malnutrition. We conclude that serum proteins usually measured inusing reference values of a normal population. Using BMI, triceps
clinical practice give poor predictions about nutritional status ofskinfold, MAC and mid-arm muscle circumference we graded each
haemodialysis patients. However, high levels of A2M was a markerparameter reduction: .90% score 1 (normal), 90–80% score 2, 80–60%
of malnutrition, having a good relation with anthropometric indexes.score 3 and ,60% score 4. We considered malnutrition when total
We propose the study of this protein as a marker of malnutrition inscore was higher than 4. We identify some degree of malnutrition in
haemodialysis patients.65.7% (23.2% moderate and 8.7% severe). Patients malnourished were
younger (Maln. 53 6 15 vs Welln. 66 6 7 years, P , 0.001). Sex and
dialysis duration were not risk factors for malnutrition appearance.
Kidney biopsy in elderly cadaveric donors. Description of a new tech-Anthropometric parameters were different between males and females
nique of a rapid procedure and their results. R. Ferrer, J.M. Pe´rezbut not when relative values were considered. KTV was different
Gadea, J.L. Go´rriz*, A. Sancho*, A. Cremades, E. Rosello´, V. Torres,between males (1.15 6 0.13) and females (1.29 6 0.15, P , 0.001) but
R. Zaragoza*, and L.M. Pallardo´*, Departments of Pathology anddid not differ in PCR (males 0.96 6 0.21 vs females 0.97 6 0.22 g/kg/
Nephrology*, Hospital Universitary Dr Peset, Valencia. Introduction:day). KTV was similar between well (1.20 6 0.16) and malnourished
The activity of the transplantation programmes is maintained due to the(1.20 6 0.15) patients. PCR did not differ between well (0.93 6 0.17
increased acceptance of elderly cadaveric donors. The kidney biopsy ofg/kg/day) and malnourished (0.99 6 0.22 g/kg/day) patients. No signifi-
these donors is crucial to determine its adequacy to be transplantedcant correlations were found between KTV or PCR and BMI, MAC
attending to the degree of glomerular sclerosis and interstitial fibrosis,or skinfolds. Weight was logically correlated with KTV (r 5 20.50, P ,
and it constitutes the histological reference to optimize the Banff crite-0.01) and PCR (r 5 20.27, P , 0.05) but when we considered males
ria in posttransplant biopsies. The donor biopsy allows to identify asand females separately, only showed significant correlations with KTV.
a new lesion the presence of an intimal arterial fibrosis, as well as ‘theType of membrane did not influence and we did not found differences
novo’ or recurrent nephropathy. The need to shorten the cold ischemiain absolute nor relative anthropometric parameters. There was no
time requires a rapid manipulation of the biopsy. Objective: To presentassociation among pH and serum bicarbonate levels and anthropomet-
a new procedure of the kidney biopsy, both for optic microscopy andric measurements. The presence of malnutrition did not influence de-
gree of anemia, EPO requirements, presence of hyperparathyroidism immunofluorescence, and the results of its application to the study of
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biopsies from elderly donors and allografts. Material and Methods: sults: The main figures are: Global incidence. 5,36% (60/1.118) AZA
group. Incidence: 7% (11/155) Double group. Incidence: 5,3% (15/283)Kidney biopsies from donors older than 60 years (20 cases) and from
allografts (4 cases) were studied optimizing the use of microwave Triple group. Incidence: 5,2% (31/594). We haven’t found significant
differences in: donor’s age, recipient’s age, type of dialysis, pretrans-technology of paraffin embedded material. The advantages over cryo-
stat is that it shows changes not visible on frozen specimens such as plant treatment with erythropoietin and number of previous trans-
plants. We have found significant differences in: Cold ischaemia time.glomerular infiltration of neutrophils, the presence of thrombi, splitting
of glomerular capillary membranes, and tubulitis. Results: The mean cold ischaemia ,24 h. Incidence: 4,2% (35/833); cold ischaemia .24
h. Incidence: 9,2% (18/195); RR 5 2,2 (1,27 2 3,89) P , 0,05. Conclu-time of the procedure was 120 minutes (105 to 150 min.), and the mean
of glomeruli examined was 25 (15 to 60 glomeruli). In 16 cases the sions: The incidence of primary renal graft thrombosis hasn’t increased
in patients with renal transplantation and cyclosporine treatment, evenpercentage of sclerosed glomeruli was less than 20%, and the degree
of interstitial fibrosis correlated with the percentage of glomeruloscle- with different doses in relation to other types of immunosuppression.
The cold ischaemia > 24 h is a risk factor for primary renal graftrosis. In four posttransplant biopsies a diagnosis of ATN (2 cases) and
acute rejection (2 cases) were made. Conclusions: It was possible to thrombosis.
obtain a proper histological diagnosis in two hours. This methodology
allowed us to evaluate the adequacy of kidneys from elderly donors
and to obtain a rapid and accurate diagnosis in posttransplant biopsies. Influence of acute tubular necrosis on transplantation outcome. P.
Go´mez-Ullate; J.J. Amena´bar; J.M. Urbizu; G. Garcı´a-Erauzkin; S.
Za´rraga, and I. Lampreabe, Nephrology Department, Hospital de
Cruces, Vizcaya. Introduction: The impact of acute tubular necrosisProphylaxis with OKT3 at half dose. A prospective study. M.L. Sa´nchez
Nun´ez, E. Go´mez, L. Tricas, S. Aguado, M. de On˜a, C. Portal, J. Baltar, (ATN) on the survival and functioning of the implant in the long term
has been the object of much controversy. Patients and methods: WeR. Navascues, A. Laures, and J. Alvarez Grande, Nephrology and
Immunology Service, Hospital Central Asturias, Spain. Immunosup- have reviewed the incidence and duration of ATN in 1,085 kidney
transplants carried out from July 79 to March 97 and its relation withpressive therapy with OKT3 is effective in the treatment and prophy-
laxis in renal transplant rejection. However, this has important second- the survival and functioning of the implant, evaluating I.S. with or
without CsA, cold ischemia, retransplants, age of the donor and ofary effects and it is related with a greater incidence of infections.
Recent studies have demonstrated that lower doses than normal are the receiver and RA. Results: Global incidence of ATN: 322/1,058
(30.5%). With IS without CsA: 32% vs. 30%, with CsA (NS). Coldequally effective. An open, prospective, randomized study was made
to compare the efficacy of prophylaxis with OKT3 at half dose (2.5 ischemia $24 hours: incidence of 41% vs. 28% when ,24 hours (P ,
0.001). Age of the donor ,65 years: incidence of 29% vs. 46% when $mg/day) with normal dose (5 mg/day) in non-hyperimmunized first
time transplant. Twenty subjects were randomized (10 per treatment). 65 years (P , 0.05). Age of the receiver ,65 years, incidence of 31%
vs. 30% when $65 years (NS). Retransplants, incidence of 29% vs.Four patients (2 in each group) were excluded due to: loss at follow
up, having received less than 6 doses and lack of data. Lymphocyte 38% in first time transplants (P , 0.005). With RA, incidence of 35%
vs. 26% without RA (P , 0.01). The survival of the implant at 1, 3subpopulations CD2 and CD3 were monitorized during the course of
treatment. If the percentage of CD3 was greater than 20%, the previous and 6 years was 82%, 73% and 57% in the group with ATN vs. 82%
74% and 66% in the group without ATN (P , 0.07). The Crp at 1, 3dose was duplicated. Follow up was over 12 months. Both groups
were similar according to sex, age of recipients and donors, HLA-DR and 5 years was of 1.94, 1.83 and 2 mg/dl respectively in the group
with ATN vs. 1.57, 1.56 and 1.47 mg/dl in the group without ATNidentity, pretransplant antibodies, CMV-IgG of receptor, and days of
treatment except in the global doses of OKT3 (35 mg in the group (P , 0.001 in the three periods). Comparing the duration of ATN
,14 days or $14 days in the group with ATN, there were no significantreceiving 2.5 mg vs 90 mg in the group receiving 5 mg). No significant
differences were found between both groups in the duration of NTA differences either in the survival of the implant or of the Crp at 1, 3
and 6 years. Conclusions: Incidence at ATN of 30.5% not influenced(14.9 6 8.2 vs 14.3 6 3, P 5 0.8), number of rejections per year (0.63
6 0.7 vs 1.0 6 1.0, P 5 0.4), cortico-resistant rejections (0 vs 0), and by the immune suppressor treatment. Cold ischemia, the age of the
donor, retransplant and the existence of RA do influence the incidencelymphocyte subpopulations (CD3: 16.7 6 7 vs 23.3 6 13, P 5 0.2;
CD2: 49.1 6 8 vs 50.3 6 8.8, P 5 0.7). However, a greater incidence of ATN, but the age of the receiver does not. The survival of the
implant and the degree of renal functioning, in the long term, is worseof symptomatic infection for CMV was found in the group with greater
doses, although this was not significant (0 vs 3, P 5 0.2). In conclusion, in patients and ATN. The duration of the ATN does not influence the
results.OKT3 to dose of 2.5 mg/day is as effective as to dose of 5 mg/day.
The number and the severity of the rejections are similar in both
groups. The decrease of the CD3 cells is also similar.
CMV antigenemia and PCR in patients with ganciclovir preemptive.
M.L. Sa´nchez, E. Go´mez, A. Verdugo, C. Potal, J. Baltar, R. Alvarez,
A. Laures, S. Aguado, M. de On˜a, and J. Alvarez Grande, NephrologyThe influence of the immunosuppressor therapy in primary renal graft
thrombosis. P. Gomez-Ullate, J.J. Amenabar, I. Gimeno, G. Garcia and Microbiology Service, H. Central de Asturias, Spain. Antigenemia
and PCR are known methods of diagnosis of CMV infection. TheyErauskin, S. Zarraga, and I. Lampreabe, Nephrology Department, Hos-
pital Cruces, Bizkaia, Spain. Objective: The primary renal graft throm- usually precede the onset of symptoms about the first month posttrans-
plant. The aim of the trial was to investigate if ganciclovir prophylaxisbosis is a serious complication of kidney transplantation that causes
graft loss. The cyclosporina is one of the factors that has been impli- have any effect on the appearance of CMV infection. From 11/93 to
6/96, 138 consecutive renal transplants were prospectively studied. 13cated. We have studied the incidence of the primary renal graft throm-
bosis in the different types of immunosuppression, and others possible were excluded by follow minor of 3 month, leaving 121 available for
study. Ganciclovir was administered simultaneously to all patients re-factors in relation. Materials and methods: We have reviewed the
incidence of primary renal graft thrombosis in kidney transplantations ceiving OKT3 prophylaxis (28 patients) together with prednisone, aza-
thioprine, and cyclosporine when creatinine ,3 mg/dl. The remainingperformed from July in 1979 to March in 1998 according with the type
of immunosuppression: AZA group: We observed 155 transplantations 53 patients received neither OKT3 nor ganciclovir, only prednisone,
azathioprine and cyclosporine. Antigenemia-CMV and PCR-CMVfrom 1979 to 1985 and the therapy was azathioprine1prednisone. Dou-
ble group: We studied 283 transplantations from 1986 to 1993 and were performed weekly during the 4 first posttransplant months. The
57% (16/28) of the patients with ganciclovir and the 56% (52/93)the therapy was cyclosporine (10–14 mg/kd/day)1prednisone. Triple
group: We followed 594 transplantations from 1989 to 1997 and the without ganciclovir had antigenemia (P 5 0.3). Duration of antigene-
mia were similar in both groups (28 6 32 vs 27 6 28 days, P 5 0.9).therapy was (6–8 mg/kg/day)1prednisone1azathioprine). In addition,
we have considered other factors like donor’s age, recipient’s age, sex, However, the time from the transplant at first positive antigenemia is
greater in patients with ganciclovir (72 6 28 days) that in patientsnumber of previous transplants, pretransplant treatment with erythro-
poietin, type of dialysis, time of cold ischaemia (.24 h vs. ,24 h), and without ganciclovir (49 6 22), P 5 0.001. Only 32% (9/28) of patients
with ganciclovir had PCR positive vs 16% (15/93) without ganciclovir,the incidence of primary renal graft thrombosis. We used the Mantel-
Haenzsel’s relative risk (RR), to indicate this stratified relation. Re- P 5 0.1. Duration of PCR1 were similar in both groups (23 6 32 vs
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20 6 19, P 5 0.9). First PCR1 also appeared later in patients with deposition, especially in the medullary rays of the renal cortex. Al-
though both deposits were slightly more intense in the group givenganciclovir (65 6 17) that in patients without ganciclovir (42 6 11),
P 5 0.0005. Antigenemia was more frequent than PCR in patients with the low-salt diet, the difference in comparison with rats fed with the
standard diet was not significant. P-gp overexpression showed a strongganciclovir (57% vs 32%, P 5 0.04, McNemar) and without ganciclovir
(56% vs 16%), P , 0.0001, but the time of appearance since the inverse correlation with the incidence of hyaline arteriopathy (r 5
20.65, P , 0.01), periglomerular fibrosis (r 5 20.58, P , 0.05), peritu-transplant was similar (72 6 28 vs 65 6 17, P 5 0.5 with ganciclovir
and 49 6 22 vs 42 6 11, P 5 0.7 without ganciclovir). No patients bular fibrosis (r 5 20.63, P , 0.05) and angiotensin II deposition (r 5
20.70, P , 0.01). Conclusions: Our results support the hypothesis thatwith ganciclovir and 2 without ganciclovir had symptomatic infection
(P 5 0.1). Ganciclovir prophylaxis did not decrease antigenemia and P-gp overexpression plays a detoxicating role in the kidney, and may
control the generation of toxic intracellular metabolites derived fromPCR CMV, but delay his appearance. Antigenemia was more frequent
than PCR. CsA or the catabolism of signal transduction proteins (methylcysteine
esters). In this connection, we recall that the angiotensin II-dependent
pathway for cellular activation is dependent in turn on the ras protein.
Cytomegalovirus immune globulin therapy for CMV prophylaxis in
high-risk renal allograft recipients. J.J. Amena´bar, M.L. Mun˜iz, M.P.
Martı´nez, J. Bilbao*, M.P. Figuero*, P. Go´mez-Ullate, and I. Lam- Immunohistochemical quantification of leukocyte subsets in the long-
term prognosis of kidney transplants. E. Vergara, M. Go´mez-Morales,preabe, Departments of Nephrology and *Pharmacy, Hospital Cruces,
Baracaldo, Spain. The risk of developing CMV disease after renal C. Ramı´rez, A. Osuna, R. Carvia, P. Becerra, T. Martinez, P. Galindo, C.
Asensio, and R.G. Del Moral, Department of Pathology and Nephrologytransplantation is higher in seronegative patients receiving grafts from
seropositive donors (R2D1). We report our experience with prophylac- Service, University Hospital and Virgen de las Nieves Hospital of Gra-
nada, Spain. Introduction: Since 1993 the Banff scheme for acute kidneytic administration of cytomegalovirus immune-globulin in these pa-
tients. Methods. From 1993 to 1997, 424 cadaver renal transplants were graft rejection has gained acceptance, although its usefulness in pre-
dicting the long-term course of the graft is still unclear. Patients andperformed in our unit. 24 R2D1 patients who received prophylaxis
with CMV immune-globulin (Cytotectt, 1 ml/kg, 6 doses at 3 week Methods: We compared the classical system (CS) of acute kidney
graft rejection with the Banff scheme (BS) in 51 posttransplant kidneyintervals) and 15 seropositive recipients without prophylaxis and trans-
planted with corresponding pair kidney, as controls, were retrospec- biopsies from patients with acute rejection. The biopsies were assessed
according to the modified Sanfilippo criteria [interstitial rejection (IR 5tively evaluated. Results: Recipient age, sex, time on dialysis, retrans-
plants, transfusions pre and post-Tx were similar in both groups. 23 22 cases), glomerulo-interstitial rejection (GIR 5 14), vasculo-intersti-
tial rejection (VIR 5 12), 2 cases undetermined] and the Banff classifi-R2D1 (96%) and 14 R1D1 (93%) patients were treated with Triple
therapy (Cya 1 Aza 1 Pred), two other patients received Mycopheno- cation [borderline (5 cases), grade I (11), grade II (16), grade III (12),
7 biopsies insufficient for diagnosis]. Results: The types of rejectionlate. In R2D1 group 13 patients (54%) underwent acute rejection and
received 6-Metil prednisolone IV vs. 9 patients (60%) in R1D1 group identified with each system were related with clinical and morphologi-
cal parameters indicative of the severity of the lesions, with the number(2 required OKT3). Of the 24 patients on prophylactic therapy 16
(67%) became CMV positive, 12 (50%) developed mild CMV disease of the different leukocyte subpopulations, and with CsA deposits in
renal tissue as identified immunohistochemically. In neither of the two(fever 6 leukopenia 6 liver dysfunction) and 1 patient (4%) had CMV
tissue invasive disease. The time of onset of CMV disease in these systems was severity of rejection significantly related with clinical or
prognostic factors, with the exception of cumulative dose (g) of CsApatients was 48 (Range 20–158) days. In the control group 2 patients
(13%) developed mild CMV disease at 37 and 111 days posttransplant. in the CS (VIR: 23.51 6 9.38, GIR: 20.82 6 8.21; IR 2.21 6 9.51,
Kruskal-Wallis P , 0.05) and time to appearance of rejection in theConclusions: CMV immune globulin does not prevent CMV infection
in seronegative recipients but may have a beneficial effect on the BS (borderline: 25.25 6 15.75, GIII: 85.71 6 160.84, Kruskal-Wallis P ,
0.05). A correlation with myointimal fibrosis was found only in the CSseverity of CMV disease.
(chi-squared P , 0.01). Severity of rejection according to the CS
correlated significantly with the number of inflammatory cells in the
Role of P-glycoprotein in chronic cyclosporin A nephrotoxicity and glomerulus (CD45, CD3, CD4, CD8 Kruskal-Wallis P , 0.001); macro-
its relationship with intrarenal angiotensin II deposits. R.G. Del Moral, phages (ANOVA P , 0.001); and CD16 (Kruskal-Wallis P , 0.05).
M. Andu´jar, C. Ramı´rez, M. Masseroli, A. Olmo, M. Aguilar, F. Arreb- With the BS a similar correlation was found only for the number of
ola, M. Guille´n, and F. O’Valle, Department of Pathology, School of CD45 cells per mm2 in the interstitium (borderline 2006.22 6 1078;
Medicine and University Hospital of Granada, Spain. Introduction: P- GIII 3780.26 6 1912.65, ANOVA P , 0.05). Conclusions: 1) The Banff
glycoprotein (P-gp), expels hydrophobic xenobiotics from the cyto- classification is highly useful in grading the intensity of acute rejection
plasm, including chemotherapeutic and immunosuppressive agents lesions, but does not correlate well with clinical parameters. 2) Al-
such as cyclosporin A (CsA), tacrolimus and rapamycin. Chronic CsA though little significant correlation was obtained with the classical
treatment of cultured renal tubule cells induces P-gp overexpression system, the diagnostic grades more closely paralleled the values ob-
in the cell membrane. Angiotensin II was recently implicated as one tained with immunohistochemical techniques. 3) The use of immuno-
of the main factors in progression toward CsA-induced interstitial histochemical techniques to quantify leukocyte subsets in the intersti-
fibrosis. Material and Method: To experimentally verify the effects of tium and glomerulus in kidney graft rejection is a promising approach,
CsA in vivo, we developed a model of chronic CsA nephrotoxicity. as these results appear to be related not only to the intensity of kidney
We treated 80 Sprague-Dawley rats with 25 mg/kg/day CsA for 4 and damage but also to the patient’s clinical course.
8 weeks. During this time the animals were fed a normal diet or a
low-salt diet. Conventional histological parameters of nephrotoxicity
(isometric tubular vacuolization and hyaline arteriopathy) were ana- Protective effect of verapamil and isradipine in chronic cyclosporin A
nephrotoxicity in rats. Mediating role of endothelins and angiotensinlyzed, and interstitial fibrosis was quantified with the digital image
analysis program Fibrosis HR in conventional slides stained with Sirius II. C. Ramı´rez, A. Olmo, M.J. Garcı´a-Chicano, M. Andujar, D. Alema´n,
F. O’Valle, R.G. Del Moral, and M. Aguilar, Department of Pathology,red. Immunohistochemical studies were performed with streptavidin-
biotin-alkaline phosphatase method to analyze tubular expression of School of Medicine and University Hospital of Granada, Spain. Intro-
duction: Part of the mechanism responsible for cyclosporin (CsA)P-gp with a cocktail of specific monoclonal antibodies (1 5 normal
expression, 2 5 mild overexpression, 3 5 moderate/intense overexpres- nephrotoxicity is mediated by the endothelin system. Calcium antago-
nists partially revert the action of endothelin in experimental physio-sion) and the presence of intrarenal angiotensin II deposits in the
external medulla and medullary rays of the kidney (mild, moderate pathological studies. We compared the protective action of the calcium
antagonists verapamil and isradipine in an animal model of CsA neph-or severe deposition). Results: All CsA-treated rats developed chronic
nephrotoxicity lesions, which were more obvious in animals given the rotoxicity, and studied the relationship between drug action and the
endothelin system. Material and Methods: Six groups of 10 Spague-low-salt diet (85% with hyaline arteriopathy, P , 0.05). Treatment
with CsA also induced evident overexpression of P-gp in tubular cells Dawley rats were studied: CsA at 25 mg/kg/day dissolved in Cremophor
(CsA); solvent only administered (CR); isradipine at 5 mg/day (ISR);of the kidney, and large differences in the intensity of angiotensin II
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verapamil at 10 mg/kg/day (VER); isradipine 1 CsA (ISR 1 CsA); P-glycoprotein expression in acute kidney graft rejection. E. Vergara,
C. Ramı´rez, M. Go´mez-Morales, A. Osuna, G. Alvarez, M. Palomares,verapamil 1 CsA (VER 1 CsA), at the same doses as in the groups
F. O’Valle, A. Olmo, M. Aguilar, C. Asensio, and R.G. Del Moral, De-given only one of the drugs. All substances were administered subcuta-
partment of Pathology and Nephrology Service, University Hospital andneously during 1 month. Laboratory analyses and RIA for endothelins
Virgen de las Nieves Hospital of Granada, Spain. Introduction: P-Glyco-were done in serum-plasm and urine from each animal. Blood pressure
protein (P-gp) has a detoxicating function and expels hydrophobic sub-was measured centrally by cannulating the carotid artery. The animals
stances from the cells. Earlier studies suggested that cyclosporin Awere killed and the kidneys removed for conventional histological
(CsA) can stimulate P-gp expression in kidney cells in vivo and instudies and IHQ (glomerular expression of endothelins 1 and 3 and
vitro, and that the most acute cases of kidney graft rejection are relatedangiotensin II). Fibrosis was quantified automatically, and molecular
with larger intrarenal deposits of CsA. Patients and Methods: To ana-biology analyses (Northern blot of endothelin 1 and 3 mRNA) were
lyze the prognostic value of P-gp expression in acute kidney graftdone. Results: Laboratory results revealed altered renal functioning
rejection, we analyzed protein expression immunohistochemically inin group CsA (Ccr 210 ml/min/100g, ANOVA P , 0.001). Central
51 posttransplant kidney biopsies. Immunohistochemical findings forblood pressure in rats with nephrotoxicity was lower (P , 0.01) in
P-gp were rated semiquantitatively (1 5 normal or mild overexpressionanimals given the calcium channel blockers and CsA. Fibrosis was
and 2 5 moderate and intense overexpression; the last group includedsignificantly greater in CsA group (P , 0.001). In plasma from CsA-
all the cases with expression of P-gp on infiltrating inflammatory cells),treated rats, lower total endothelin levels were associated with higher
and were related with clinical and prognostic parameters, histologicalactive endothelin levels; the opposite was found for urinary clearance lesions indicative of CsA nephrotoxicity, Banff grade, CsA intrarenal
of endothelins. In endothelin 3 mRNA expression was greatest in deposits, and the number and location (glomerular or interstitial) of
group CsA. Blood central pressure correlated directly with angiotensin different leukocyte subsets in the biopsy. The latter two parameters
II expression in kidney tissue. Conclusion: 1) Calcium antagonists and were evaluated with immunohistochemical techniques. Results: The
CsA show a synergistic hypotensive effect. 2) The protective effect intensity of P-gp overexpression was inversely related with serum creat-
against CsA-induced nephrotoxicity was similar in both calcium antag- inine after follow-up and directly with the severity of rejection ac-
onists. 3) The protective effect may be mediated in part by the endo- cording to the Banff scheme, graft survival in days (2235 6 953.5,
thelin system. 1217 6 595, Student’s t test P , 0.05) and with glomerular leukocyte
quantification CD45 (12.1 6 12.3 vs 19.1 6 12.1, P , 0.05); CD4 (6.5 6
13.2 vs 10.7 6 8.2, P , 0.05). In the interstitium P-gp overexpression
Nephrotoxic drug-induced modifications in glycoprotein-p expression was related with leukocyte counts: macrophages (1794 6 832 vs 2376 6
in cell lines of renal origin. F. Arrebola, M. Guillen, F. Revelles, M. 1042, P , 0.05); CD4 (1764 6 898 vs 2328 6 796, P , 0.05) and
Aguilar, M.E. Reguero, F. O’Valle, and R.G. Del Moral, Department CD16 (309 6 417 vs 608 6 607, P , 0.05). Intensity of P-gp expression
of Pathology, School of Medicine and University Hospital of Granada, correlated directly with the number of CsA deposits (P , 0.001).
Conclusions: 1) Overexpression of P-gp is responsible for more severeSpain. Introduction: The role of P-glycoprotein (P-gp) as a detoxicating
acute rejection crises, a connection probably related with the develop-mechanism in the kidney has been recently described. This transmem-
ment of lymphocyte resistance to immunosuppressor treatment. 2) Dif-brane protein is expressed on the apical border of kidney proximal
ferences in P-gp expression in kidney and the lack of correlation be-tubules and in cultured cell lines of renal origin. The main function
tween protein expression and serum CsA levels may be responsibleof P-gp is to act as a hydrophobic “vacuum cleaner” of xenobiotics.
for individual variations in susceptibility to severe immunosuppressiveWork Hypothesis: Prolonged exposure of renal tubule cells to nephro-
drug-resistant rejection crises and chronic CsA nephrotoxicity.toxic agents induces P-gp overexpression as a compensative mechanism
of detoxification. Failure of this system leads to the development of
nephrotoxicity. Material and Methods: Cell lines MDCK and LLC-
Survival prediction factors in end stage renal disease replacement ther-PK1 were maintained in MEM with 5% fetal bovine serum. The culture
apy (RRT). C. Dı´az Corte, F. Ortega, P. Rebollo, J. Baltar, R. A´lvarez,cell assays were performed by long incubation with sublethal doses
F. A´lvarez-Ude, X. Badı´a, J. Guederiaga, A. Diaz Fonseca, C. Mejido,(IC70) of several chemotherapeutic agents [doxorubicin (DOX), daun- M. Gorostidi, P. Escalada, M. Ban˜os, and J. A´lvarez Grande, Hospitalorubicin (DAU), vinblastine (VIN), purine and pyrimidine base ana-
Central de Asturias, Instituto “Reina Sofı´a” de Investigacio´n Nefrolo´g-logs (BA), acycloguanosine (Aciclovir), 39-azide-39-deoxythymidine
ica, Oviedo, Espan˜a. Introduction: The number of patients who are(AZT), 2939dideoxy inosine (DDI), cytosine b-D-arabino-furanoside
started on RRT is constantly increasing, thus, it is essential to know(ARA-C)], ACE Inhibitors (captopril, enalapril), gentamicin, and im-
what life expectancy is being offered, as well as those survival predictionmunosuppressive drugs [cyclosporin A (CsA) and azathioprine]. Flow
factors that are related to it. Material and methods: Retrospectivecytometry was used to determine P-gp expression with indirect immu- study of sample including over 80% of the patients (468) who werenofluorescence using the monoclonal antibody JSB-1 and the influence started on RRT in our region between 1985 and 1994, in order to find
of drug treatment in cell cycle. We recorded the number of positive survival prediction factors, analysing global and univariate (Kaplan-
cells (%POS) and mean specific fluorescence (MSF). Results: Chemo- Meier) survival, as well as relative death risks using Cox multivariate
therapeutic agents (especially VIN) were the most toxic, whereas ACE method. Results: In our sample, global survival at 12, 24, 60, and 96
inhibitors were the least toxic. Under basal conditions both cell lines months was of 90%, 82%, 61% and 50%, respectively. Mean survival
expressed similar amounts of P-gp: MDCK %POS 83.65 6 22.71, time was 80 months, with a reliability interval of 95% (I.C.95) between
MSF 23.39 6 7.28; LLC-PK1 %POS 81.28 6 20.5, MSF 22.44 6 9.22. 75 and 85 months. When comparing survival curves, significative differ-
Incubation with all drugs modified MSF in both lines (ANOVA, P , ences were observed for the following: age (P , 0.0005), dialysis centre
0.01) and induced changes in the cell cycle (ANOVA, P , 0.001). P-gp (P , 0.001), main diagnostic (P , 0.0001), functional status (P ,
expression increased in phase S and G2M (Pearson’s test, r 5 0.69). 0.0001), having received renal transplant (P , 0.0001), hemoglobin
The following drugs induced statistically significant changes in P-gp level in blood (P , 0.05), serum creatinine level (P , 0.005), comorbid-
expression in line MDCK: DAU (MSF 59.72 6 8.02, %POS in S 1 ity index (P , 0.0001). Univariate analysis did not report significative
G2M 62.01 6 10.36), ARA-C (MSF 47.56 6 7.84, %POS in S 1 G2M differences concerning survival time of RRT patients with respect to:
55.43 6 7.44); CsA (MSF 37.7 6 2.96, %POS in S 1 G2M 33.33 6 4.25). year of therapy initiation, sex, marital status, hematocrit and serum
In line LLC-PK1 the significant changes were: VIN (MSF 33.85 6 5.22, urea level. When the multivariate model was applied, it was observed
%POS in S 1 G2M 22.62 6 9.29), AZT (MSF 41.62 6 2.65, %POS in that death risk (RR 5 1.4) was reduced by variable “having received
S 1 G2M 76.18 6 4.8), CsA (MFS 37.35 6 6.01, %POS in S 1 G2M a transplant” and that death risk was increased by variables “main
34.55 6 2.46). The BA and chemotherapeutic and immunosuppressor diagnostic 5 diabetes” (RR 5 1.73), “functional status” (RR-1 5 6.18;
agents produced the largest increases in MSF (ANOVA, P , 0.01). RR-2 5 1.5) and “Concomitant disease 5 sight problems” (RR 5
Conclusions: 1) Nephrotoxic drugs produce overexpression of P-gp in 1.4). Influence of the remaining variables from univariate model was
kidney cell lines. 2) To obtain reproducible results and ensure adequate invalidated. Conclusions: Prediction factors found: 1) “having received
quality control for P-gp expression, cell cycle should be simultaneously a transplant,” which invalidates the influence of age and Hb and Cr
plasmatic levels, after three months on RRT; 2) diabetes mellitus asevaluated.
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main diagnostic (but not: nephrosclerosis, glomerulonephritis, intersti- Social Functioning (SF) 5 93.54 6 14.54; Role Emotional (RE) 5
86.73 6 31.43; Mental Health (MH) 5 79.05 6 16.64; Significativetial nephritis, polycystosis, and others); 3) Functional status at start of
RRT, and 4) sight problems (and not the rest of comorbidity problems). associations (Student’s T-test; P , 0.05): Female patients were associ-
ated with worse functional status (lower KS score), and worse HRQOL
(higher score on PCE’s diFis and diPsc, and lower scores on SF36
dimensions: PF, RP, D, V, FS and SM). Higher age was associated toSurvival predictors in elderly patients on end stage renal disease re-
placement therapy (RRT). P. Rebollo, F. Ortega, J. Baltar, C. Dı´az worse functional status and worse HRQOL (lowest FF on SF36). PT
from PCE was higher (worse HRQOL) in patients with worse economicCorte, R. A´lvarez, F. A´lvarez-Ude, X. Badı´a, J. Guederiaga, A. Diaz
Fonseca, C. Mejido, M. Gorostidi, P. Escalada, M. Ban˜os, and J. A´lv- level, patients with lower educational level and patients with longer
hemodialysis treatment before renal transplant. “Nephroangiosclerosis”arez Grande, Hospital Central de Asturias, Instituto “Reina Sofı´a” de
Investigacio´n Nefrolo´gica, Oviedo, Espan˜a. Introduction: At the mo- as main diagnostic was associated with worse score on SF-36 FS dimen-
sion. Conclusions: Functional Status and HRQOL in sampled patientsment, the fastest growing number of RRT patients is found among
elderly young patients (.65 and ,75 years), and elderly old patients bearing a renal graft, are satisfactory and close to those of general
population. There are significative differences in obtained HRQOL(.75 years). Since on the one hand, life expectancy is reduced, and
on the other, there are patients who are capable of surviving several measures, that can be attributed to age, sex, socio-economic level and
dialysis period before transplant.years with a good quality of life, this study pretended to find factors
which could predict their evolution. Material and Methods: Retrospec-
tive study of sample including over 80% of patients who started RRT
in 9 centres of the region between 1985 and 1994, in order to compare Improvement in quality of life in patients on dialysis after normalisation
of hematocrit with erythropoietin (EPO). Spanish ESRD Patient’selderly patients (157, from which 123 were elderly young, and 25 elderly
old) with the remaining patients (314) through the analysis of survival Quality of Life Study Group. Co-ordinators: F. Moreno*; D. Sanz-
Guajardo**; J.M. Lo´pez***; R. Jofre***; and F. Valderra´bano***,predictors by means of Kaplan-Meier’s univariate analysis and Cox’s
multivariate analysis. Results: Survival comparison showed significative *Hospital Universitario Prı´ncipe de Asturias, Univ. de Alcala´; **H.
Puerta de Hierro; ***H. General Universitario Gregorio Maran˜o´n. Thedifferences with respect to: age (P , 0.0005 elderly patients against
,65 years and P . 0.0001 elderly young patients, opposite to elderly preliminary results of the multi-center Spanish study on the increase
in hematocrit and quality of life (QL) in hemodialysis are presentedold patients), dialysis centre (P , 0.01), main diagnostic—diabetes
mellitus vs the other diagnostics—(P , 0.01), hemoglobin (Hb) (P , in the following paragraph. The main objective of the study was to
learn whether the increase in hematocrit to figures up to 40% with0.05), and especially, functional status (SF) (P , 0.0001) with survival
rates of 20, 76 and 82% after two years, and 0.36 and 63% after five erythropoietin, implies an improvement in QL indicators (Sickness
Impact Profile [SIP] and Karnofsky Scale) of the patients. To date,years, respectively, according to SF level, the same as in the total
sample. Univariate analysis did not show significative survival differ- 152 patients from 29 hospitals started the study. At submitting of this
paper, 117 patients have completed the six-month monitoring. Of these,ences with respect to: year of therapy initiation, sex, number of concom-
itant diseases, and urea, creatinine, total proteins and albumin levels. 27 were excluded, as they did not meet the criteria for inclusion.
Inclusion criteria were as follows: 1-Basal Hb or hematocrit $ 9 gr./Survival rates after one, two and five years for ,65 years and elderly
patients were 92, 85 and 66%, opposite to 84, 76 and 45%, respectively dl or $ 30% respectively and basal hematocrit , 35%; 2-Achievement
of hematocrit increase of at least four points above the basal figure.(P , 0.0005). Mean survival time was 85 months (I.C.95 5 79–91) and
59 (I.C.95 5 52–66) for the latter. Survival rates after two years (only Mean age was 45 yr. old and 59% of the patients were male. The mean
increase in Hb and hematocrit was 2.3 gr./dl and 7.8% respectively.possible comparison period between elderly young and elderly old
patients) were 80 and 49%, with mean survival time of 60 (I.C.95 5 Nine patients were excluded because of vascular access thrombosis
52–68) and 46 years (I.C.95 5 30–62), respectively. Conclusions: Sur- (6%) and one due to a hypertensive emergency. There were no deaths
vival prediction factors found in elderly patients are: 1) age (especially during the study period. The following table shows the evolution of
for .75 years), 2) diabetes mellitus as main diagnostic, 3) Serum scores (mean and median) obtained on the SIP:
hemoglobin levels and 4) functional status at RRT initiation.
6th P
Health-related quality of life (HRQOL) in renal transplant receptor Basal Month (Wilcoxon)
patients. P. Rebollo, F. Ortega, C. Dı´az Corte, J. Baltar, R. A´lvarez,
Physical dimension of SIP 5.3 (3.2)* 3.9 (1.3) ,0.005X. Badı´a, F. A´lvarez-Ude, and J. A´lvarez Grande, Hospital Central de
Psychosocial dimension of SIP 8.8 (6.9) 6.1 (4.6) ,0.0001Asturias, Instituto “Reina Sofı´a” de Investigacio´n Nefrolo´gica, Oviedo,
Global score of SIP modified** 7.8 (6.3) 5.7 (1.7) ,0.0001Espan˜a. Introduction: HRQOL in end-stage renal disease patients who
Hematocrit 30.7% 38.5%receive a renal transplant is clearly better than HRQOL in dialysis
pats, and similar to that of healthy persons. Objectives: To assess * 27 cases scored “0” at the onset
HRQOL in patients who bear a renal graft, and to find associations ** Does not include “Work” partial category.
between it and several socio-demographic and clinical variables. Mate-
rial and Methods: Sample included 186 transplanted patients under 65
years showing no cognitive problems, who were interviewed using Conclusion: There has been an improvement of quality of life indicators
HRQOL assessment instruments: Sickness Impact Profile (SIP), and after increasing hematocrit figures, despite the fact that the patients
Health Survey Questionnaire SF-36. In addition, socio-demographic included started the study with good functional status. The incidence
and clinical data, Karnofsky Scale (KS) scores, and a detailed Comor- of adverse effects related to the increase in hematocrit or erythropoietin
bidity Index were gathered. Results: (mean value 6 standard deviation was low.
is shown) Description of studied sample: 1) age 5 47.39 6 10.97; 2)
sex 5 65.6% male; 3) renal disease diagnostic 5 NA (8.6%), DM
(8.1%), GN (36.2%), NI (17.3%), PQ (11.9%), Others (17.8%); 4) Short OKT3 induction for kidney retransplantation. J. Pascual, R.
Marce´n, T. Cano, G.F. Jua´rez, L. Orofino, F.J. Burgos, F. Lian˜o, andmonths on hemodialysis 5 26.53 6 33.13; 5) months with transplant 5
55.51 6 43.28; 6) Hb 5 13.49 6 2.11mg/dl; 7) Cr 5 2.11 6 1.68 mg/ J. Ortun˜o, Servicios de Nefrologı´a y Urologı´a, Hospital Ramo´n y Cajal,
Madrid, Spain. The short term results of renal retransplantation aredl; 8) albumin 5 4.71 6 3.51 g/dl; 9) N8 of admittances 5 142 patients
(76.3%) none during the last year; 10) Comorbidity Index 5 1.61 6 probably related to the efficacious prevention of severe acute rejection
episodes. Similarly, long term results could be related with the develop-1.19 diseases; 11) Karnofsky Scale (E.K.) 5 83.28 6 9.78. HRQOL
assessment instruments scores: PCE: physical dimension (diFis) 5 ment of chronic rejection, one of the most important determinants is
probably the number and severity of acute rejection episodes. There3.04 6 5.57; psychosocial dimension (diPsc) 5 6.34 6 8.56; total score
(PT) 5 8.22 6 6.11; SF36: Physical Functioning (PF) 5 84.31 6 11.89; is not adequate evidence supporting aggressive induction protocols
including monoclonal antibodies for first cadaveric renal transplanta-Role Physical (RP) 5 88.17 6 28.37; Bodily Pain (BP) 5 80.38 6 24.70;
General Health (GH) 5 64.79 6 21.67; Vitality (V) 5 74.48 6 17.53; tion. The results of such attempts in retransplantation are even more
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scarce. In an open label way, between January 1995 and December (CyA) basal immunosuppression, and the information about prognosis
1996 we have performed 8 kidney retransplantations including a short and complications of RRT in the CyA era is not extensive. During
period of initial induction with monoclonal antibodies (OKT3 5 days, the last 10 yr we have performed 450 cadaveric renal transplantations
5 mg iv each day) with cyclosporine introduction (8 mg/kg/day po) at with a standard protocol including CyA and steroids. Four hundred
4th day independently of graft function. Seven patients underwent and four of them were first transplants and 46 RRT. The induction
their second transplantation and one his third procedure. All donors protocol for the RRT patients included four iv boluses of 6-methylpred-
were cadavers and the recipients were 5 males and 3 females aged nisolone of 250 mg each (days 0–3) while first transplants received
40 6 11 years. Six of them had glomerulonephritis as the underlying only one on day 0. The last 8 RRT received 5 OKT3 boluses also. Mean
nephropathy, one interstitial nephritis and one nephroangiosclerosis. age and sex distribution were similar in both groups. Demographic data
The cause of first renal allograft loss was: acute rejection (n 5 4), of the donors were also similar. HLA-DR matching, cold and warm
vascular thrombosis (n 5 2), chronic rejection (n 5 2). In this small ischemia times, percentages of delayed graft function and length of
group of patients we observed an unexpectedly high percentage of hospitalization were similar. Acute rejection episodes developed in
delayed graft function (6/8, 75%; 40% in our overall series of 670 kidney 49% of first renal transplants and in 50% of RRT (NS). Treatment
transplants). No immediate or medium term complications related to requirements were not different. Actuarial survival rates were:
OKT3 treatment could be identified. Two patients (20%) developed
acute rejection episodes: one of them was resolved after 9 moderate
steroid pulses and the other one was steroid-resistant and required 5
1 yr 3 yr Log-rank testadditional OKT3 boluses of 5 mg each to be controlled. One patient
developed linfocele and another one an ureteral leak that required Patient First 97% 94%
surgical reconstruction. Only two patients presented infections: both RRT 96% 93% P 5 0.13
were mild urinary tract bacterial ones. After a mean follow-up of 13 6 Graft First 83% 76%
8 months the 8 grafts are functioning (mean serum creatinine 1.8 6 RRT 71% 65% P 5 0.16
0.4 mg/dl) without ongoing complications (100% of patient and graft
survival). Our results with this short series of kidney cadaveric retrans-
plantations support short OKT3 induction in these patients. Low inci-
The incidence of complications arising from the surgical wound, thedence of acute rejections and very low rate of infections constitute the
linfoceles, urinary leaks or urinary tract stenosis were not different.most important combination of features with this protocol.
RRT recipients had a higher incidence of vascular thrombosis, but the
difference did not reach statistical significance. The distribution of
causes of graft loss was different between the two groups. No RRTHepatitis C virus infection reduces the severity of acute rejection and
recipients lost the graft as a consequence of acute rejection, while 21increases infections in renal transplantation. J. Pascual, M. Crespo, R.
first transplants did (0 vs 18%, P 5 0.07). Graft loss secondary toMarce´n, L. Orofino, M.L. Mateos, F.J. Burgos, F. Mampaso, F. Lian˜o,
chronic rejection was similar (28 vs 25%). The most frequent causeand J. Ortun˜o, Servicios de Nefrologı´a, Urologı´a y Anatomı´a Patolo´gica,
of graft RRT loss was vascular thrombosis (39% of all losses had thisHospital Ramon y Cajal, Madrid, Spain. Hepatitis C virus (HCV)
origin). Mean serum creatinine at one year and thereafter was similarinfection could negatively influence graft and patient survival after
renal transplantation (RT). We have assessed the influence of HCV in functioning first transplants and functioning RRTx. Our data support
infection on long-term results of our RT program. Between 1986 and RRT in patients immunosuppressed with CyA and steroids. Long-
1996 we have performed 450 RT immunosuppressed with cyclosporine term patient survival is excellent. Short-term graft survival is slightly
and steroids: 79 were done in HCV1 patients and 369 in HCV2 ones. worse than in first transplants probably due to a higher incidence of
We have compared clinical evolution and complications between both vascular complications.
groups. The prevalence of confirmed HCV infection was 18%. Age,
sex and donor data were similar between HCV1 and HCV2. Actuarial
patient and graft survival were: Usefulness of backtable angioscopy in kidney transplantation. J. Pas-
cual, F.J. Burgos, V. Go´mez, N. Cruz, C. Carrera, L. Orofino, R.
Marce´n, and J. Ortun˜o, Servicios de Nefrologı´a y Urologı´a, Hospital
Patient survival Graft survival Ramo´n y Cajal, Madrid, Spain. Vascular thrombosis and renal artery
stenosis (RAS) influence graft survival after kidney transplantation1 yr 5 yr 1 yr 5 yr Log rank
(KT). The usefulness of pre-KT angioscopy of the allograft in the
HCV1 92% 77% 82% 60% P 5 0.0015 prevention of these complications has been scarcely evaluated. The
HCV2 98% 92% 81% 71% P 5 0.084 aim of the study is to analyze the usefulness of backtable angioscopy
to detect vascular pathological conditions of the renal allograft pre-
viously to KT and to define the value of this technique to establish
The incidence of acute rejection was similar in both groups (HCV1 the quality of microsurgical vascular reconstructions. Twenty-five allo-
47% vs HCV2 49%) but the impact of acute rejection as a cause of grafts from high risk vascular donors have been backtable angioscopi-
graft loss was lower in HCV1: no patient in this group lost the graft cally evaluated with a 7F flexible angioscope. Wisconsin solution was
due to acute rejection vs 22% in HCV2, P 5 0.0006. The treatment used as irrigation fluid. Donors were older than 60 years, with severe
of acute rejection required less frequently OKT3 in HCV1 (5%) than aortic atheromatosis, polytraumatized, with cardiac arrest or with vas-in HCV2 (20%). The incidence of infections was higher in HCV1
cular lesions or anatomic anomalies of renal vessels that need vascular(mean 1.9 episodes per patient vs 1.2 episodes in HCV2, P 5 0.02).
anastomoses in bench. Forty-four percent (11/25) of the grafts showedLiver disease as a cause of death was more frequent in HCV1 patients
vascular pathological conditions on angioscopy: subintimal haematoma(24% vs 3%, P 5 0.025 Fisher). HCV infection could induce an immu-
(2), intimal tear (2), atheroma plaques (2), venous thrombosis (1),nodeficient state that may explain lower severity of acute rejection
and vascular injuries that need microsurgical vascular reconstructionand higher incidence of infections, mainly bacterial ones. Milder drug
previously to KT (4). The graft in which a venous thrombosis wasimmunosuppression protocols might be advisable in this population.
incidentally detected was not transplanted. All the kidneys with bench
surgery showed angioscopically satisfactory anastomoses. All of them
were transplanted. Renal allograft angioscopy is useful in selectedRenal retransplantation in cyclosporine-treated patients. J. Pascual,
cases previously to KT. It allows us to evaluate vascular state of theG.F. Jua´rez, T. Cano, R. Marce´n, J. Herruzo, L. Orofino, F. Lian˜o,
graft. Some segmentary intrarenal thrombosis that do not modify graftF.J. Burgos, F. Mampaso, C. Quereda, and J. Ortun˜o, Servicios de
perfusion in bench can be angioscopically detected. Some RAS of theNefrologı´a, Urologı´a y Anatomı´a Patolo´gica, Hospital Ramo´n y Cajal,
graft can be diagnosed and repaired previously to KT. Angioscopy isMadrid, Spain. Renal retransplantation (RRT) has a worse short and
useful to detect anastomotic pitfalls of surgical reconstructions, poten-long term prognosis than first renal transplantation. Most of the pub-
lished series include recipients with conventional and cyclosporine tial causes of KT thrombosis.
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Influence of transfusional requirements and erythropoietin treatment FK506 patients presented a lower incidence of biopsy proven acute
during periodic dialysis period on posttransplant anemia recovery. rejection than Cyclosporine group in the first year. Incidence of acute
J. Pascual, M.T. Tenorio, A. Tato, R. Marce´n, L. Orofino, J.J. Villa- rejection in high risk patients on FK506 group was higher than the
fruela, F.J. Burgos, F. Lian˜o, and J. Ortun˜o, Servicios de Nefrologı´a y total FK506 group (24%), but lower than the total Cyclosporine group
Urologı´a, Hospital Ramo´n y Cajal, Madrid, Spain. During the immedi- (43.4%). Frequency of side effects and infections were similar in both
ate posttransplant period after renal grafting, the development of ane- groups. In conclusion, in high risk renal transplant patients an immuno-
mia is frequent. It is usually attributed to blood losses, hemodilution suppressive regime including FK506 provides a lower incidence of
and acute inflammatory state related to surgery, infection or rejection. acute rejection and a better graft survival at 12 months than a
In addition, the graft does not produce enough erythropoietin yet. Cyclosporine based regime. These data suggest that FK506 by its immu-
With the end-aim of evaluating the possibility of early erythropoietin nosuppressive potency could be especially useful in immunologically
treatment after kidney transplantation (KT) we have assessed the high risk patients.
evolution of red cell production recovery in 50 cadaveric KT receptors,
25 under erythropoietin treatment during dialysis (14 of them during
more than one year) and 25 without it. Basal immunosuppression was Mycophenolate mofetil slows the decline of renal function in patients
cyclosporine and steroids. Age was 44 6 14 years, 32 were males and with biopsy-proven chronic rejection. A pilot study. J.M. Morales,18 females. 48% had delayed graft function and 52% had at least one J.M. Campistol, J. Segura, A. Mazuecos, A. Osuna, F. Oppenheimer,acute rejection episode during the year of follow-up. Up to 70% had
A. Andre´s, and A. Go´mez de la Ca´mara, Hospital 12 de Octubre, Clinic,received blood transfusion before KT (not electively) because of vari-
Ca´diz & Granada, Spain. Mycophenolate Mofetil (MMF) is a newable reasons. Hemoglobin (Hb, g/dl) and hematocrit (Ht, %) courses
immunosuppressive drug, that could prevent chronic rejection in exper-are depicted in the table:
imental models. The purpose of this study was to evaluate prospectively
if MMF added to immunosuppressive treatment in patients with estab-
lished chronic renal transplant rejection (CRTR) demonstrated byDay
biopsy could modify the rate of renal function deterioration. 31 cadav-
PreKT 12 14 18 114 130 160 eric renal transplant patients from four Units of Spain were included
in the study. All were diagnosed of CRTR according with the criteria
EPO pre SI Hb 11.2 8.8* 8.9* 9.91 9.91 10.6 11.71 of Alexis Carrel conference. Patients with ACEI inhibitors and/or
Hc 33.5 26.2* 26.8* 29.41 29.71 31.2 34.7 suggestive pathological signs of cyclosporine nephrotoxicity were ex-
EPO pre NO Hb 10.4 8.4* 9.31 9.9 10.6 11.1 12.01 cluded. After biopsy all received MMF, 2 gm daily associated to original
Hc 31.1 24.9* 27.81 29.7 31.9 33.2 36.61 therapy (10 double, 9 CyA monotherapy) or after Azathioprine was
(*p , 0.001, 1p , 0.01 vs basal preKT) discontinued (10 triple and 2 Prednisone and Aza). Shown below are
SCr, CyA doses (mg/kg/d) and levels prior and after MMF administra-
tion.No significant differences were detected in graft function during post-
KT period between both groups. Patients who had received pre-KT
erythropoietin treatment had slower recovery of hematologic parame-
ters and took longer in overpassing basal hemoglobin. 44% of all 26 Mo. 0 Mo. 16 Mo.
patients needed post-KT transfusions (38% 1–4 times, 6% .4 times), Mean values MMF basal P MMF
more frequently the females (P , 0.05). Acute rejection was unrelated
SCr (mg/dl) 2.17 6 0.90 2.78 6 0.90 ,0.05 2.59 6 0.70with transfusional requirements. Pre-KT erythropoietin treatment did
CyA dos. 3.18 6 1.47 2.80 6 1.13 ,0.01 2.61 6 1.15not determine more post-KT transfusions. Pre-KT transfusional need
CyA lev. ng/ml 167 6 50 144 6 55 ,0.01 120 6 51was the parameter most directly related with post-KT transfusional
need: only 2 out of the 15 never transfused patients required post-KT
blood vs 20 out of the 35 pre-KT transfused (Fisher P 5 0.001). Multiple
logistic regression showed female gender (OR 2.68 P 5 0.005) and Individual changes in the rates of the reciprocal SCr were measured
pre-KT transfusional requirements (OR 2.66, P 5 0.005) to be the only as the slope of a line fitted to the data by the regression coefficient
parameters significantly related to post-KT blood need. Erythropoietin estimated by least squares measures before and after MMF, demonstra-
treatment during dialysis determines post-KT hemoglobin recovery. ting a significant improvement after MMF was started (20.02121 vs
This factor, in addition to others such as pre-KT transfusional require-
20.00008, P , 0.001). Renal function improved in 19 of 31 patientsments or the gender, should be taken into account when designing (61%). Although CyA doses and levels diminished after MMF, therecontrolled trials of post-KT erythropoietin treatment.
were no statistical differences in the follow-up between groups when
we divided all patients depending on CyA doses (above or below 3.5
mg/Kg/d) and CyA levels (above or below 150 ng/dl). In conclusion,Efficacy of tacrolimus (FK506) and cyclosporine (sandimmun) in high
MMF added to immunosuppressive treatment slows the decline ofrisk renal transplant patients. J.M. Morales, and A. Andres on behalf of
renal function in the short-term in patients with biopsy-proven chronicthe European Multicentre Tacrolimus Study Group. Hyperimmunized
rejection. It suggests that prospective and multicenter studies to evalu-patients, who had more than 80% of cytotoxic antibodies, and/or re-
ate MMF efficacy in these CRTR are mandatory.transplanted patients, who lost their first kidney in the first postrans-
plant year, are considered as a high risk group to present acute rejection
and in terms of graft survival after renal transplantation. The aim
of the present study was to compare the efficacy of FK506 versus Fibrosing cholestatic hepatitis. A new, early and severe complication
Cyclosporine in high risk patients. Thirty three patients, from the after renal transplantation. J.M. Morales, E. Mun˜oz de Bustillo, C.
European Multicentre Study (open, randomized 2:1, comparing a triple Ibarrola, F. Colina, A. Andre´s, G. Castellano, R. Gota, and J.L. Rodicio,
therapy combination based on FK506 vs a triple therapy based on Nephrology, Pathology & Hepatology Departments, Hospital 12 de
Cyclosporine), were identified as high risk people by criteria mentioned Octubre, Madrid, Spain. Severe fibrosing cholestatic hepatitis has been
above and included in the study. Twenty two received FK506 and 11 exceptionally reported after renal transplantation (RTx). From 1075
Cyclosporine and demographic data in both groups were comparable. renal transplant (RT) patients followed since September 1976 to No-
Incidence of acute rejection (AR), graft (GS) and patient survival (PS) vember 1996, seven patients developed FCH. The aim of the present
is shown in the table. study was to report the first series of this liver complication after renal
transplantation. Patients’ mean age was 40.7 years (range: 34–68). Five
were males and 2 females. All were preRTx HBsAg negative. PreRTx
antiHCV antibodies were determined in 5 patients by ELISA2/RIBA2,
being positive in 4 patients and negative in one. One patient wasn Acute rejection GS PS
negative by ELISA1, and the other was unknown. All donors were
Tacrolimus 22 31.8% 86.4% 100% HBsAg and antiHCV negative. All received CyA, steroids and azathio-
Cyclosporin 11 54.5% 72.7% 90.9% prine (AZA). The latter drug was administered during a mean period
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of 14.7 months (1 week–48 months), and was withdrawn when liver to receive MMF 2 g and 3 g, respectively, and 166 patients were given
PLA. After 1 yr, comparator patients stopped taking PLA.disease was diagnosed. Strikingly, the clinical onset appeared early
after RTx: mean time 7.5 months (range 1–36). The clinical picture was
determined by hyperbilirubinemia (6.5–21 mgrs/dl) and high Alkaline
Intent-to-treat analysis at 3 yearsPhosphatase levels (428–1800 IU/l) in all but one case. All patients
(1 year)exhibited increased GGT levels (660–3524 IU) and mild AST and ALT
abnormalities. A biliary cause of cholestasis was excluded in all cases. MMF 2 g MMF 3 g PLA
CMV infection was detected in one case. Liver biopsy was performed
Graft loss, including death (%)* 14.6 (8.5) 18.8 (10.0) 21.9 (11.4)after a mean period of 18.8 months after RTx (range 4–48). All liver
Deat (%)* 6.7 (3.0) 8.2 (3.8) 11.1 (5.4)specimens showed a similar histological pattern characterized by peri-
Graft loss due to rejection (%) 4.8 (1.8) 6.3 (3.8) 10.8 (4.8)portal diffuse fibrosis with mild leukocyte infiltrates and different de-
Lymphoma (%) 0.0 (0.0) 1.3 (0.6) 0.0 (0.0)grees of cholestasis. Outcome was awful: five patients died of hepatic
Premature termination (%) 34.5 (24.2) 48.8 (35.6) NA (36.7)failure 23.4 (6–50) months after RTx. One patient is alive after receiving
* Kaplan-Meier rateliver transplant 29 months after RTx, and the last one is awaiting
combined kidney and liver transplant. In summary, fibrosing cholestatic
hepatitis is a new, early and often fatal complication after RTx. Its Differences in 3-yr graft loss rates (including death) and 95% confi-
etiology is unknown, although HCV infection could play an important dence intervals for comparisons of PLA vs MMF 2 g and 3 g, respec-
pathogenic role in some cases as well as perhaps other viruses and tively, were 7.3% (20.4%, 15.1%) and 2.9% (25.0%, 10.8%). Acute
AZA therapy. allograft rejection was the predominant reason for graft loss in all
treatment groups. After the first year, diarrhea and anemia were the
most relevant adverse events, but they occurred predominantly in the
MMF 3 g group. Only 1 patient (MMF 3 g) developed CMV disease.Increased lipoproteins and fibrinogen in chronic renal allograft dys-
Over the 3-yr posttransplant period, 2 patients in the MMF 3 g groupfunction. C. Ferna´ndez-Miranda, E. Mun˜oz de Bustillo, J.M. Morales, developed lymphoma/LPD. The number of other (non-LPD, noncuta-
A. Porres, J. Gomez-Gerique, C. Guijarro, J.L. Aranda, A. Andre´s, neous) tumors was 3 (MMF 2 g), 2 (MMF 3 g), and 5 (PLA). In
J.L. Rodicio, and A. Del Palacio, Servicios de Medicina Interna y conclusion, continued use of MMF 2 g over a full 3-yr study period
Nefrologı´a, Hospital 12 de Octubre, Unidad de Lı´pidos, FJD, Madrid. decreased the incidence of transplant failure from 21.9% to 14.6%.
Chronic rejection—also called chronic renal allograft dysfunction Graft failure rate with MMF 3 g was 18.8%. These differences were
(CRAD)—is the main cause of long-term loss of the transplanted not statistically significant, since this study was neither designed nor
kidney, but its pathogenesis is not well known. The aim of this study was powered for this long-term survival endpoint.
to know if lipoproteins, fibrinogen, plasminogen activator inhibitor-1
(PAI-1) and platelet aggregation show more abnormalities in renal
A pilot study of sirolimus versus cyclosporine in a triple-therapy regi-transplant patients with CRAD than in those with stable renal function.
men with corticosteroids and azathioprine for the prevention of acuteSixty patients with renal allograft have been studied; 20 patients with
renal allograft rejection. Preliminary results at three months. J.M.CRAD and 40 controls matched for age, gender and time after trans-
Morales, J.M. Capistol, and A. Andres on behalf of the European Siroli-plantation. In a univariate analysis patients with CRAD had higher
mus Renal Transplant Study Group. In several animal models, sirolimustotal serum triglycerides (214 6 153 vs. 133 6 39 mg/dl; P 5 0.04) and
(SRL; Rapamune) has been as effective as cyclosporine (CsA) invery-low-density lipoprotein (VLDL) triglycerides (128 6116 vs. 59 6
preventing rejection, without the potential for nephrotoxicity, neuro-29 mg/dl; P 50.04). Apolipoproteins B levels were also increased in toxicity and hypertension. Complementary to a previous phase II study
patients with CRAD although this difference was only borderline sig- using SRL in combination with CsA, the present pilot study was de-
nificant (131 6 58 vs. 98 6 16 mg/dl; P 5 0.05). Similarly, there was signed to evaluate SRL as a replacement to CsA in human renal
a trend toward increased total, VLDL, and low-density lipoprotein transplantation. This was an open, randomized and European multicen-
(LDL) cholesterol and reduced high-density lipoprotein (HDL) choles- ter study (Sweden, France, Spain and UK, eleven centers). SRL or
terol in CRAD patients, but these differences did not reach statistical CsA neoral was given in combination with azathioprine (2 mg/Kg)
significance. Apolipoprotein A-1 and lipoprotein(a) levels were similar and tapering doses of corticosteroids to patients aged 18–65 years, with
in both groups. Neither platelet aggregation nor PAI-1 levels differed primary functioning cadaveric kidneys. CsA and SRL were concentra-
tion controlled (CsA: ,2mo, trough 200–400 ng/ml; .2mo, troughbetween both groups. In contrast, fibrinogen was increased in patients
100–200 ng/ml; SRL ,2mo, trough 30 ng/ml, .2mo, trough 15 ng/ml).with CRAD (373 6 81 vs. 322 6 62 mg/dl; P 5 0.01). In a multivariate
Eighty-three patients were enrolled (42 CsA and 41 SRL). The incidenceanalysis triglycerides and fibrinogen were positively correlated to
of acute rejection at one month (biopsy or clinically proven, intentionCRAD. These findings add further support to the hypothesis that lipid
to treat analysis) were 41.5% and 40% for SRL and CsA respectively.abnormalities may be involved in the pathophysiology of CRAD. In
At 3 months the incidence of acute rejection was 49% for SRL andaddition, this is the first report showing that fibrinogen levels are
43% for CsA. To date, 2 additional acute rejection episodes occurredincreased in patients with CRAD. Further studies are needed to evalu-
in the CsA group after 3 months of treatment, none in the SRL group.ate a potential role of fibrinogen in the development of CRAD. There were 3 graft losses in the CsA group (one rejection and 2 thrombo-
sis) and 1 in the SRL group (rejection and sepsis). There have been
no deaths in either group. The more frequently observed laboratory
abnormalities in the SRL group were reduced leukocyte and plateletEuropean mycophenolate mofetil trial: 3-year results. J.M. Morales,
counts and hyperlipidemia. In conclusion: These results suggest thatJ.M. Grinyo, A. Andre´s, and J.L. Rodicio, for the European Mycophe-
SRL is as effective as CsA preventing acute rejection in renal transplantnolate Mofetil Study Group. The European mycophenolate mofetil
patients when combined with azathioprine and corticosteroids. SRL(MMF) prevention of acute renal allograft rejection trial [1-yr, double-
appears to have less nephrotoxic potential than CsA.blind, placebo (PLA)-controlled] showed that MMF 2 g and 3 g when
added to a standard double-drug regimen of cyclosporine and cortico-
steroids significantly reduced the incidence of acute rejection/treatment Immunosuppressive treatment in idiopathic membranous glomerulo-
failure at 6 months from 56.0% for PLA to 30.3% for MMF 2 g and nephritis with progressive renal function worsening. J. Segura, E. Mo-
38.8% for MMF 3 g (P , 0.005). To determine how this reduction rales, J.C. Herrero, R. Alegre, E. Herna´ndez, and M. Praga, Hospital
would influence long-term graft survival, patients treated with MMF 12 de Octubre, Madrid, Spain. Treatment of idiopathic membranous
2 g and 3 g continued in an open, 2-yr, follow-up study. Patients in glomerulonephritis (MGN) is a controversial question. We have ana-
the PLA group were only followed up for graft/patient survival and lyzed the evolution of 32 patients with MGN that developed progressive
renal insufficiency (SCr . 1.5 mg/dL and CrCl , 50 ml/m). 19 patientsmalignancies. Of the initial 491 patients, 165 and 160 were randomized
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(Group 1) did not receive immunosuppressive treatments and were study; 43 of them continued with mh despite the correction of HC/
treated with conservative measures. The remaining 13 patients (Group 2) HU with thiazides/allopurinol, but in the remaining 12 p (belonging
were treated with oral prednisone for 6 months (1 mg/Kg/day during to 5 families) mh disappeared with the treatment (mh associated with
the first month) plus oral chlorambucil (0.15 mg/Kg/day) for 4 months. HC/HU). In 30 out of the remaining 49 non-diagnosed families, a renal
There were no differences in age (Group 1: 55.1 6 17, Group 2: 48.8 6 biopsy was performed in one of the family members: a thin-basement-
19 years) nor in renal function (SCr 2.1 6 0.9 vs 1.9 6 0.5 mg/dL) membrane nephropathy (TBMN) was observed in 27 (including 71 p)/
between both Groups, whereas proteinuria was higher in Group 2 (8.4 6 30 families, and IgA nephropathy (IgAN) in 3 (9 p)/30 families. Families
3 vs 11.1 6 3 g/day; P , 0.002). Follow-up was 5.2 6 3.2 years in with TBMN showed a high prevalence of HC/HU (39%) and nephroli-
Group 1 and 4.9 6 2.5 years in Group 2 (P NS). Using Kaplan-Meier thiasis (55%). After a follow-up of 7.2 6 3.9 years, all the 135 p
analysis, 48% of Group 1 patients had SCr . 2 mg/dL and 25% were maintained normal renal function. 7/135 p (5%) developed proteinuria .
on dialysis after 4 years of follow-up. By contrast, all the patients of 0.5 g/day, and 19 p (14%) hypertension. Those families (13) diagnosed
Group 2 showed SCr ,2 mg/dL (P , 0.05). After 8 years of evolution, of Alport’s syndrome by renal biopsy in the same period of the study,
84% of Group 1 had SCr . 2 mg/dL and 70% were on dialysis, whereas always showed proteinuria and/or renal insufficiency in addition to
20% of Group 2 showed SCr . 2 mg/dL and 20% needed dialysis (P , mh, and the evolution was unfavourable. In conclusion, TBMN is the
0.05). At the end of follow-up, SCr was 6.9 6 3.2 in Group 1 and 1.6 6 commonest cause of persistent and isolated familial mh, followed by
1.4 mg/dL in Group 2 (P , 0.001) and proteinuria 5.8 6 2.8 vs 3.4 6 mh associated with HC/HU and IgAN. TBMN is associated with HC/
3.3 g/day (P , 0.05). There were 5 deaths in Group 1 and none in HU and nephrolithiasis. Long-term prognosis is good.
Group 2. Principal complications of immunosuppressive treatment in
Group 2 were pneumocystis carinii pneumonia (2 cases), herpes zoster
(4), steroid psychosis (1) and avascular bone necrosis (1). In conclusion,
Renal transplant from cadaveric kidney donors older than 60 years.treatment with oral steroids plus chlorambucil exerts a clear favorable
J.C. Herrero, A. Andr´es, E. Morales, J. Segura, A. Roca, R. Alegre,influence on MGN with progressive renal insufficiency.
M. Praga, J.L. Rodicio, and J.M. Morales, Nephrology Department,
Hospital 12 de Octubre, Madrid. The shortage of kidney donors and
the growing waiting list for renal transplant are the major factors toThe absence of biochemical repercussion of nephrotic proteinuria
expand the limit age to accept cadaveric renal donors. From Januaryallows the distinction between primary or hyperfiltration-related focal
1990 to March 1997 we have performed 677 renal transplants, 83 ofsegmental glomerulosclerosis (FSG). E. Morales, R. Alegre, J.C. Her-
them (12%) from cadaveric renal donors older than 60 year (64 6 10rero, J. Segura, J.M. Morales, and M. Praga, Hospital 12 de Octubre,
years, r:61–76). The recipients of these 83 renal transplants were 32Madrid, Spain. Primary FSG and FSG secondary to hyperfiltration are
female and 51 male, mean age 59 6 7 years, r:29–76. All of them werevery difficult to distinguish histologically. We have previously reported
immunosuppressed with Cyclosporin A. The cold ischemia time was(AJKD 17:330–338, 1991) that those patients with nephrotic protein-
22 6 5 hours and the rate of acute tubular necrosis reached 65%.uria that do not develop hypoalbuminemia show specific clinical charac-
teristics. We have recategorized all our patients diagnosed with FSG by Thirty-three percent of the recipients had acute rejection. The three
renal biopsy in the period 1975–97 according to the following criteria: years graft and patient actuarial survivals were 60% and 92% respec-
nephrotic-range proteinuria (.3.5 g/day) and serum albumin , 3 g/dL tively. Twenty-six patients lost the renal transplant: 5 acute rejection,
(Group 1) or .3.5 g/dl (Group 2) in at least 3 consecutive measurements 7 died, 6 chronic rejection, 4 surgical complications and 4 primary
in the 3-month period before renal biopsy. 30 patients met these crite- nonfunction. Seven patients died because: infection in 4 cases, gastroin-
ria. Group 1 (hypoalbuminemia: 2.1 6 0.2 g/dL) included 13 patients testinal haemorrhage in 1 case, cardiovascular disease 1 case and suicide
(8 M, 5 F): the study had not shown any cause of secondary FSG in the remaining case. In conclusion, the patient and graft actuarial
and were diagnosed of primary FSG. On the contrary, in Group 2 survival of renal transplant from donors older than 60 years are satisfac-
(normoalbuminemia: 3.9 6 0.3 g/dL) that included 17 patients (18 M, tory. The recipients of these renal transplants should be also older
4 F), only 2 cases (11%) had been diagnosed of primary FSG. In the patients because they have a lesser expectancy of life.
remaining cases, a clinical etiology suggesting hyperfiltration-related
FSG had been observed: massive obesity (body mass index .35) in
8, grade IV vesicoureteral reflux in 5 and renal mass reduction .50% Simultaneous double renal transplant from very old donors. A. Andres,
in 2. In addition to the differences in serum albumin, Group 1 patients J.M. Morales, M. Praga, T. Ortu˜no, E. Hernandez, J.L. Rodicio, R.
showed hypoproteinemia (4.5 6 0.5 vs 6.6 6 0.4 g/dL; P , 0.001). No Diaz, G. Polo, and O. Leiva, Nephrology and Urology Department,
patient of Group 2 showed edema whereas all Group 1 patients had Hospital 12 de Octubre, Madrid. In general, kidneys from very old
nephrotic edema. Proteinuria at the moment of renal biopsy was higher donors, although presenting normal renal function, are discarded for
in Group 1 (10.3 6 2.9 vs 6.1 6 1.7 g/day; P , 0.001). There were no renal transplant because they have reduced renal mass due to age anddifferences in age, renal function nor blood pressure. In conclusion,
other pathologies like hypertension and diabetes. A way to increasepatients with FSG secondary to hyperfiltration do not develop hypopro-
transplanted renal mass in order to use these very old donors is ateinemia, hypoalbuminemia nor the other characteristic findings of
simultaneous double renal transplant. From November 1996 to Aprilnephrotic syndrome (edema, extreme hyperlipidemia) despite massive
1997 we have done five simultaneous double renal transplant fromproteinuria values. The recognition of this peculiarity could help in
very old donors. The criteria for double renal transplant were: normalthe distinction between the different forms of FSG.
donor serum creatinine, donors older than 75 years or, if donor age
was 60–75 years the kidney frozen biopsy before transplant had to
show a percentage of glomeruloesclerosis higher than 15%. DonorsPersistent and isolated familial microhematuria. Etiology, clinical char-
were 4 female and 1 male, aged 80 6 5 years (r:76–89). Pretransplantacteristics and long-term follow-up. M. Praga, R. Alegre, J. Vara, J.
renal biopsy showed a mean of 18 6 7% of glomeruloesclerosis. TheSegura, A. Andr´es, M. A. Mart´inez, and J.L. Rodicio, Hospital 12 de
recipients were 4 female and 1 male, aged 61 6 2 years. One kidneyOctubre, Madrid, Spain. We have followed a prospective protocol in
was placed in the right and the other in the left iliac area. Immunosup-order to identify families with persistent microhematuria (mh). Those
pression was triple therapy including Micofenolate Mofetil and usingpatients (p) with persistent (.5 erythrocytes per h.p.f. in at least 3
low Cyclosporine doses (5 mg/Kg/day). The cold ischemia time was 21consecutive sediments during 6 months) and isolated (normal renal
6 6 hours. One patient, with severe aterosclerosis, showed immediatefunction, no proteinuria) mh were asked for a similar study of first-
thrombosis of both kidneys. The remaining four patients had immedi-degree relatives. When some of them showed the same abnormality,
ate renal function. With a mean follow up of 3 6 1.5 months nobodythe diagnosis of persistent familial mh was established. 54 families,
presented acute rejection and the mean serum creatinine is 1.2 6 0.3including 135 p met these criteria. The presence of hypercalciuria
mg%. Patient survival is 100%. In conclusion, when donors are very(HC) and hyperuricosuria (HU) was systematically investigated; when
old, the simultaneous double renal transplant is a good procedure toobserved, p were treated with thiazides or allopurinol, respectively.
reach a good renal function in the recipient. This technique open new31/135 p (22%) had had bouts of gross hematuria superimposed on
persistent mh, 55/135 p (40%) showed HC and/or HU at the initial perspectives to improve the utilization of renal donors.
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Renal transplantation in Hepatitis B surface antigen-positive (HBsAg) hepatitis). 67% of the patients are either free of liver disease or present
only mild hepatic dysfunction. On the contrary 33% developed severepatients. Consequence of use HBsAg positive donors. J. Segura, A.
liver disease (2 out of them died). The group D1/R1 (N 5 14) didn’tAndres, J.C. Herrero, J.M. Morales, E. Morales, A. Roca, R. Alegre,
present a poorer evolution than the group D2/R1 (N 5 13).M. Praga, and J.L. Rodicio, Nephrology Department, Hospital 12 de
Octubre, Madrid. From 1982 we have performed 1028 renal transplants.
Twenty-seven of them were done in HBsAg positive recipients (21
Acute Chronicmales, 6 female, aged 40 6 11 years). The donors of 14 out of 27
Number hepatitis hepatitis Exitusrecipients were HBsAg positive (D1/R1) (N 5 14) and the remaining
donors were HBsAg negative (D2/R1) (N 5 13). Before the renal D1/R1 14 1 (7%) 4 (28%) 1 (7%)
transplant, only five patients had mild liver dysfunction. The remaining D2/R1 13 2 (15%) 5 (38%) 3 (23%)
recipients were asymptomatic. Twenty-six received an immunosuppres-
sive protocol with Cyclosporine A. The mean follow up was 87 6 46
months. The rate of acute rejection was 40%. Patient and graft survival The recipients of renal transplantation with HBsAg positive have more
were 85% and 52% respectively. We lost the follow up of 1 patient. risk to develop acute and chronic hepatitis. Nevertheless a higher
Four patients died: 1 fulminant hepatitis, 1 hepatocarcinoma, 2 sepsis. percent of them are either free of liver disease or with mild liver
Three patients developed severe acute hepatitis after the first six dysfunction. The group transplanted with HBsAg donors positive had
no more risk to develop hepatic dysfunction.months of evolution (1 of them is the patient who died by fulminate
